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Californium 252 sources were used in a clinical
environment for neutron activation analysis studies for a
period of 2-g- years. During this period changes in part
body calcium in bone, in response to different treatment
regimes, were measured in patients suffering from primary
or secondary bone disease.
Measurements were performed on peripheral bone, in
252
particular the forearm, using two sources of Cf, minimum
total activity 56 mCi, and a purpose built partial body
counter. Optimisation of the irradiation geometry and the
patient irradiation programme enabled calcium measurements
to be performed with a precision of between 1.5$ and 1.8$
and a bone dose less than 3 rem.
The following clinical studies were undertaken: the
effect of 1-oc-hydroxycholecalciferol on 19 patients under¬
going chronic haemodialysis, the us e of vitamin I>2 or
in the treatment of 33 patients with potential anticonvul¬
sant osteomalacia, the effect of lithium carbonate in 15
patients with manic depression and the efficacy of conven¬
tional treatments in combating thyrotoxic osteodystrophy.
Apparatus was also developed to measure calcium
252
changes in the lumbar spine. Two Cf sources of total
activity 200 mCi were used for irradiation and a whole
body counter for detection of the induced activity. A
precision of 2$ was obtained for patient measurements,




Neutron activation analysis is one of the few avail¬
able techniques for non-destructive analysis of elemental
composition. Hence its potential, as a clinical tool for
in-vivo measurements on human subjects, requires evalua¬
tion.
Of all the body elements that can be measured using
neutron activation analysis, calcium is almost certainly
of most interest. The technique of neutron activation
analysis is the only non-traumatic method of directly
monitoring the calcium status of a patient with a poten¬
tially high degree of precision. The purpose of this
study was to evaluate neutron activation analysis using
Californium-252 in a hospital environment over a three
year period. In particular, various forms of bone
disease were studied.
A relatively cheap system was developed initially
to measure sequential changes of calcium in the forearm.
Although the possibility of absolute calcium measurements
was investigated during the course of the project, the
clinical studies were designed on the basis of the
original decision to study sequential changes. This
decision was made because it was felt that if absolute
measurements were pursued, little or no time would be
left for sequential studies. Not only would a large
number of normal subjects have to be irradiated, which
could be deemed as unethical, but the normal range might
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be found to be so large, as the literature suggests, that
the technique would be useless as a diagnostic tool.
The main criterion in the design of the apparatus
was to obtain a sufficiently high degree of precision with
as low a dose and with as little inconvenience to the
patient as possible. Another constraint which had to be
overcome was the low activity of the radionuclide sources.
In order to evaluate neutron activation analysis,
the technique was compared with other methods of moni¬
toring calcium changes. Indirect methods of measuring
calcium from changes in the mineral density were used,
using a photon absorption technique and also radiographs.
In addition, relevant biochemical tests were performed on
all the patients. Thus activation analysis was not
evaluated in isolation, but could be compared with all
other techniques that are readily available.
Although the main purpose was to evaluate the tech¬
nique, care was taken to choose patient studies that were
clinically relevant. The studies can therefore be divided
into two categories, the first using the apparatus as a
research tool to evaluate treatment regimes in groups of
patients and the second using it as an aid in the manage¬
ment of individual patients in response to various treat¬
ments.
In addition to the work on the forearm, a technique
was developed to measure calcium changes in the lumbar
spine. This is the partial body region where calcium
losses can be most debilitating and such losses affect
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a large proportion of the elderly population. The tech¬
nique is described in detail, though no patient study
results are given as they will not start to appear for
two years.
The experimental work described in this thesis can
be divided into three main sections. Firstly, a
description is given of the apparatus and the methods
used for calcium measurements of the forearm. Secondly,
the results of the patient studies are presented and
intercomparisons between neutron activation analysis of
the forearm and other techniques are made. Thirdly, a
description is given of the method devised to measure






REVIEW OP IN-VIVO NEUTRON ACTIVATION ANALYSIS
The technique of neutron activation analysis has been
in use for in-vivo measurements of body elements in human
subjects for the past thirteen years. Absolute levels and
sequential changes of about 10 different body elements
have been studied in patients with a variety of disorders.
In particular, activation analysis is suitable for
investigating patients suffering from any form of meta¬
bolic bone disease and, in many cases, is the only method
of monitoring the efficacy of different treatment regimes.
Such clinical investigations using neutron activation
analysis have been carried out on a large scale over the
past 5 or 6 years.
In this review of in-vivo neutron activation
analysis, the emphasis is on techniques that have been
used for clinical investigations. Much has been published
by research establishments who, possessing a source of
neutrons, have carried out "feasibility studies" using
phantoms or animals. These have only been included when
they are directly relevant to patient studies. In many
cases, dose was the limiting factor in human measurements.
1.1 Body Elements Measured by Neutron Activation
Neutron activation analysis of elemental content has
been performed in general using one of three different
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types of nuclear reaction. The first, and most common,
is where a different unstable isotope of the element is
produced after thermal'neutron capture. An example of
48
this is Ca which, when bombarded with thermal neutrons
49
becomes ^Ca.
^®Ca + n( thermal)—>^Ca + X
Analysis of the induced activity can then be made after
the neutron irradiation.
The second type of reaction is when induced activity
is again produced but this time only when the incident
neutrons are above a certain threshold level. As the
neutrons are of a higher energy a (n,oc), (n, p) or
(n, 2n) reaction is likely to occur rather than a (n, X)
reaction from thermal neutrons. For example, the
following reaction can be used to analyse phosphorus from
the measurement of the induced aluminium.
51P + n(energy >2.3 MeV)—->28A1 + OQ
v
H ~ 28si + ?er
These two different types of reaction are similar in
that the measurement of the induced activity and the
neutron irradiation occur at separate times.
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The third type of reaction concerns the measurement
of the prompt gamma after thermal neutron capture. In
this case both the irradiation and the detection must bje r
done simultaneously, care being taken to minimise the
effect of the gamma spectrum from the neutron source on
the detection apparatus. An example of this is the
reaction used for the measurement of cadmium.
iWca + „^iu0d + X
Table 1.1 contains a list of all the reactions
that have been used for measurements on patients. A more
extensive list of the first two types of reactions that
can be used to measure other elements can be found else¬
where (Glaros 1975).
1.2 Neutron Sources
When reviewing the field of in-vivo neutron acti¬
vation analysis it must be remembered that more often
than not, no choice was available in the source of
neutrons used for patient measurements. This was parti¬
cularly true in the early years where existing apparatus
was utilised and the optimum patient irradiation proce¬
dure was determined.
The sources that have been used range from large
nuclear reactors to small radionuclide sources, with
vastly differing neutron spectra, the mean neutron
energies ranging from thermal to 14 MeV. The choice of
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• TABLE 1.1
Reaction <j( mb) Half Life Principal
Energy(s)
(a) Activation by Thermal Neutrons
43Ca(n,tf)49Ca 1,100 8.8 min 3.10 MeV
25Na(n, >()24Na 500 15.0 hr 1.37,2.75 MeV
37Cl(n,?038Cl 430 37.3 min 1.64,2.17 MeV
127l(n,X)128I 6,200 25.1 min 0.45 MeV
63Cu(n,*)54Cu 400 12.8 hr 0.51 MeV
(b) Activation by Neutrons above a Threshold Level
cf at Threshold
14 MeV
14N(n,2n)13N 6 10.0 min 0.51 MeV 11.3 MeV
31P(n,^)28Al 140 2.3 min 1.78 MeV 2.2 MeV
40Ca(n,o037Ar 110 35.1 day 2.6 KeV Xray
38Pe(n,p)38Mn 100 2.6 hr 0.84 MeV 5.0 MeV








the source depends on the following considerations:-
(a) The elements to be measured. The spectrum must
contain neutrons above any threshold levels required.
(b) The part of the body to be studied. Soft tissue
attenuates neutrons, so higher energy neutrons are
required for whole body measurements than part body
measurements, to. give as uniform a fluence as
possible in the region of interest.
(c) Possible interfering reactions. If neutrons of too
high an energy are used, additional unwanted thres¬
hold reactions can occur which may cause inter¬
ference .
(d) The b" spectrum from the source. If prompt gamma
measurements are to be performed, interference from
the neutron source must be kept to a minimum.
(e) The dose to the patient. Too high a neutron energy
may unnecessarily increase the dose.
(f) Finance. Not only the cost of the initial
installation must be considered, but also running
costs, and replacement costs. The running cost
will be higher for a reactor or a cyclotron and
replacement cost will be appreciable for neutron
generators and the shorter lived radionuclide
sources.
(g) Reliability. The radionuclide sources are
-15-
intrinsically the most reliable, but of the other
types of source, only the neutron generator has
any reputation for unreliability.
Of all the possible neutron sources, radionuclide
sources are probably the most suitable for clinical
studies in a hospital environment, particularly in the
case of partial body calcium measurements. The spectra
and properties of the three most common radionuclide
sources used for activation analysis are shown in
Figure 1.1.
252
The relatively low mean neutron energy of Cf
makes it an unsuitable neutron source for threshold re¬
actions listed in Table 1.1b. It does, however, make it
ideal for calcium measurements of peripheral body regions
because a lower dose per activation can be given compared
with other radionuclide sources.
1.3 Whole Body Activation Analysis
The first neutron activation measurements on human
subjects were performed by Anderson and colleagues (1964)
at Harwell. Two healthy volunteers were measured using a
14 MeV Cockcroft-Walton generator. They were placed
1.1 m from the target and covered with 3 cm premoderator.
The subject was irradiated from both sides receiving a
dose of 1 rem. After passing urine, the subject was
measured for 35 minutes in a whole body counter. Anderson
was unable to measure calcium but found that sodium and
chlorine were close to ICRP standard man values. The
-16-
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results also showed little difference "between total sodium
as determined by neutron activation analysis, and the
exchangeable sodium, as measured by isotope dilution.
The errors in the technique were investigated by
Battye(1967). He found that in the measurements of Ca,
Na and CI there were interferences of 13.2$, 3-4$ and
3.8$ from 37Cl(n,p)57S, 24Mg(n,p)24Na and 39K(n,2n)38mK
respectively. The effect of using lower energy neutrons
for the measurement of sodium was examined. It was found
(Newton et al 1969) that serious non-uniformities arose
9
below 2.5 MeV, and 5.2 MeV neutrons from a Van de Graff
accelerator were considered optimal. The method of using
a 14 MeV generator for sodium measurement was improved
(Anderson et al 1972) by scanning the patient, in a
tapered wooden coffin, passed a collimated output from
the generator. Interfering reactions were corrected for
and a value 71.6g/70kg body weight ±4$ was obtained.
Total body hydrogen was measured in 27 men and 10a 7
women using cosmic radiation (Rundo and Bunce 1966). The
prompt 2.23 MeV gamma radiation was measured and the
count rate was found to vary considerably with pressure;
14 c.p.m. at 716 mm Hg and 8.5 c.p.m. at 765 mm Hg.
Results showed a hydrogen content of 9.47$ body weight
for men and 8.65$ for women.
Whole body measurements of calcium and sodium were
performed in Birmingham using a 60 inch cyclotron. A
lithium target bombarded by 10 MeV protons gave a neutron
spectrum with an energy range of 1 - 8 MeV, peaking at
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3.5 MeV. Initiq.1 measurements were performed on 3 cadavers
and 3 volunteers (Chamberlain et al 1968a, 1968b). A
wooden coffin giving 1.5 cm premoderator was used 2 m
from the target. A dose of ^ 1„5 rem was given to the
three volunteers, then, after a delay of seven minutes,
the induced activity Was measured in a whole body counter.
Reproducibility of the method from 8 cadaver measurements
was 3.7°/". Sodium measurements compared with isotope
dilution techniques showed there to be a pool of non-
exchangeable sodium in the region of 17$ (Chamberlain et
al 1968c).
For patient measurements, 1.5 cm polypropylene pre¬
moderator was used to reduce the variation in the thermal
fluence through the first 7 cm to tl5$ from the mean
(Chamberlain et al 1970). Peaking in the forward direc¬
tion was reduced by the introduction of an aluminium
scattering cone placed in front of the target. Movement
of 10 cm by the patient towards the source had negligible
effect. The patient was irradiated while lying on his
right side facing the source for 3 min. There was a
delay of 1 min while the patient was turned over, then a
further 2 min 16 s irradiation. The patient was counted
in a fixed position for 1024 s in a whole body counter
using four 12.1 cm x 10.5 cm Nal detectors". The repro¬
ducibility of the method was estimated to be 15$
(Chamberlain and Premlin 1971). The technique was im¬
proved by using an 8 crystal whole body counter and a
precision of i2$ for a 1.0 rem dose was obtained
(Premlin et al 1977).
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A 14 MeV" neutron generator was used in Brookhaven to
measure total body calcium (Cohn et al 1970). The subject
stood on a turntable 1.5 m from the source with 3.8 cm of
premoderator in front and behind. Irradiation was for
163 s then 133 s giving a total dose of 0.637 rem.
Following a delay of 5 - 6 min, the induced activity was
repeatedly measured for 15 min using a whole body counter
consisting of fifty-four 15 cm x 5 cm Nal detectors (Cohn
et al 1969). Phantoms containing calcium were measured
and the average difference between the real and measured
value was 1.73$. Precision and accuracy of the method
was therefore estimated to be 1.7$.
The apparatus was used to measure simultaneously Ca,
Na, CI, N and P (Cohn and Dombrowski 1971a). The unifor¬
mity of thermal neutron fluence was i5$ and the maximum
variation of fast fluence through an average patient was
120$. Three repeated measurements were performed
using an Alderson phantom and the reproducibility was
1.98$, 0.74$, 3.20$, 4.40$ and 3.38$ for Ca, Ha, CI, N
and P respectively. Seventeen patients were studied and
the lean body mass derived from counts, was found to
be a good index with which to normalise the activation
results.
Apparatus was built to use the University of Wash¬
ington 60 inch cyclotron for patient measurements
following feasibility studies on phantoms and cadavers.
These results suggested that for a dose of 1 rem, total
body calcium could be measured with a precision of ll$
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and an accuracy of t8$ (Palmer et al 1967, 1968). The
neutron spectrum ranged from 4 to 12 MeV with a peak at
8 MeV and was produced by bombarding a beryllium target
with 22 MeV deuterons. For patient measurements (Nelp et
al 1970) the subject stood in an enclosure 4.5 m from the
target where the uniformity of fluence along the body was
17$. The subject stood with his arms and legs inside
perspex cylinders which were filled with water and a per-
spex cylinder was lowered over the head. This improved
the uniformity of activation over all the skeleton to
15.6$, and apart from the water and perspex cylinders, no
premoderator was used. Bilateral irradiation delivered
2.1 rem to the patient who was then measured for 12
minutes on a whole body counter incorporating four 24 cm
x 10 cm Nal detectors, the bed of which moved at an
exponentially decreasing speed. Repeated activation of
cadavers gave a reproducibility of 0.6 to 1.6$ and the
combined estimate of the precision was 2$.
With a view to performing absolute calcium measure¬
ments, 5 cadavers were measured then ashed (Nelp et al
1972a), The value of calcium per gram bone ash was constant,
as was the phosphorus to ash ratio. A relationship was
found between calcium in grams and the cube of the cadaver
height.
Ca in gms = 0.203 x ht (m) for normal men
The accuracy of the measurement was stated to be 15.2$.
A method for measuring whole body nitrogen was
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developed in Birmingham utilizing the prompt gamma radia-
15
tion emitted hy H after thermal neutron capture. Initial
animal experiments on the cyclotron (Biggin and Morgan
1971) showed that sequential measurements of H, C and 0
would be possible in patients. However for nitrogen
measurements it was suggested that 14 MeV neutrons would
be more suitable as neither carbon nor oxygen would then
be activated. A cyclotron had a great advantage when
measuring nitrogen because the neutron beam could be
pulsed and so reduce the background in the counting
apparatus. The technique used varied slightly from one
publication to another (Biggin et al 1972a,Chamberlain
and Fremlin 1972, Biggin et al 1972b)but essentially the
neutrons were collimated vertically and passed through a
patient on a bed which moved through the beam. Two 15 cm
x 15 cm Hal detectors were positioned either side of the
patient and one 12.7 cm x 12.7 cm Hal detector above, but
not in direct line with, the neutron beam. The fast
neutrons took about 15 /US to slow down so both the irra¬
diation and counting was pulsed as follows; 15 ts irra¬
diation, 5 >us wait, 150 /Us count. For a total body dose
of 0.1 rem, the measurement time was about 50 min for the
whole body or 18 min when the head, shins and feet were
excluded. Phantom measurements suggested the statistical
accuracy to be Vfo.
After using a neutron generator for several years
for neutron activation analysis, Cohn and his colleagues
at Brookhaven developed the first purpose-built apparatus
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for patient irradiation. Radionuclide sources of Pu-Be
were used, which they stated as being the ideal source for
whole body measurements of Ca, P, Na and CI (Cohn et al
1973a). Fourteen 50 Ci sources were used, positioned
evenly above and below the patient (Cohn et al 1973b).
The patient lay horizontally inside a close fitting
1.9 cm thick polyethylene premoderator which could then
be wheeled into the irradiation chamber. The neutron
fluence variation was ±4$ along the mid-axis and ±10$
and ±8$ along the front and back surface respectively.
The variation front to back through the subject, assuming
a 1 cm build up layer of tissue, was ±8$. A dose of 0.2
rem was given in 5 min to the patient then, after a 3 min
delay, a 15 min count was performed on their fifty-four
*
Ral crystal whole body counter.
Reproducibility measurements on an Alderson phantom
gave coefficients of variation of 0.99$ for Ca (based on
5 measurements) and 3.9$, 2.1$ and 1.83$ for P, CI and
Na respectively (based on three measurements) (Cohn et al
1972a). This system, as a method for measuring total
body calcium was compared with those at Birmingham,
o
Washington and with the neutron generator system at
Brookhaven (Cohn et al 1973c). It can be seen that
Cohn's Pu-Be system was obviously the superior technique,
both with regard to reproducibility and to dose, but this
was probably due more to the whole body counter rather
than to the irradiation apparatus.
A purpose built neutron irradiation facility
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incorporating two sealed tube neutron generators was built
in East Kilbride (Boddy et al 1972, 1973a). The tubes
were mounted vertically above and below the patient who
lay between the tubes on a moving couch. The generators
were housed in a concrete shield which acted as a
reflector,no premoderator being used. The patient was
counted, after 1 min delay, in a whole body counter be¬
tween two 29 cm x 10 cm Nal detectors on a bed which
moved at the same speed as the bed in the irradiation
apparatus. Such a short delay time was advantageous for
phosphorus determination. The apparatus was designed for
simultaneous measurements of Ca, P, Na, CI and N, the
^N(n,2n)^N reaction being used for the latter. The
root mean square variation of neutron fluence through a
man-like phantom was ±2.1$ and ±4.5$ for fast and thermal
neutrons respectively (Boddy et al 1974a). The reprodu¬
cibility of Ca, P and N measurements using an Alderson
phantom was 1.9$, 3-15$ and 2.63$ respectively for a dose
of about 1 rem.(Boddy et al 1973b, 1973c).
A method for measuring total body calcium with a
greatly reduced dose was investigated in animals (Palmer
1972, 1973). He used the ^Ca(n,oO^Ar reaction and
found that the time for 95$ of the Ar to leave the body
was 1 hr for rats, ijg hr for dogs and more than 2 hr for
humans. The 2.6 KeV X-rays and Auger electrons from the
37
Ar were measured in a proportional counter after being
separated from other exhaled gases. The expected dose
to humans was estimated to be 0.01 rem.
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The method was eventually developed for patient
measurements (Lewellen et al 1975) using the Washington
cyclotron for patient irradiation. The patient breathed
25c/° Og and 75^ He and was then placed on a closed circuit
breathing system for 20 - 40 min. After separation from
37
other gases the Ar was finally counted between two
23 cm x 10 cm Nal detectors for between 4 to 12 hours.
Whole body calcium was measured simultaneously on patients
37 49
using both the Ar and conventional vCa methods. Ex¬
cretion rate at 30 min correlated well with total body
calcium in 10 patients (r = 0.97). In 16 patients
studied, the maximum excretion occurred at 5 - 20 min
after irradiation and the curve could be described by a
double exponential. The average half times of the two
components were found to be 27 min and 156 min. This
compared with values of 16 min and 30 hr from a single
subject from similar work done at Birmingham (Ozbas et al
1976). Both groups estimated that dose levels to patients
would be^N/0.1 rem and Washington suggest that a precision
of l/o in a 3 hr sample would be possible using 14 MeV
neutrons.
Whole body calcium measurements were performed using
the M.R.C. cyclotron at Hammersmith (Spinks et al 1976b).
The patient stood upright sandwiched between two 5.5 cm
sheets of premoderator, a distance of 4 m from the target
emitting neutrons with a mean energy of 7.5 MeV. The
variation in neutron fluence was 15i° and il2% along and
within the patient. After bilateral irradiation and a
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dose of 1 rem there followed a delay of 3 min and then the
patient was counted in a steel room by ten 15 cm x 10 cm
Nal detectors. Six repeated measurements using a cadaver
gave a C.V. of 2fo.
Phantom measurements were performed to determine the
accuracy of the calcium measurement for absolute deter¬
minations of calcium (Spinks et al 1977). Using two
different size phantoms and measuring the effect of over¬
lying soft tissue the accuracy of the measurement was
estimated to be 18$.
Using the methods described in this section it can
be seen that whole body calcium could in general be
measured with a precision of about 2i<> though in one case
(Cohn et al 1972a) the value was 1°/o. This value of ifo
obtained by Gohn illustrates that not only is a large and
expensive neutron source necessary for whole body measure¬
ments, but that a similar degree of sophistication is
required for the counting apparatus.
The values of the precision that have been quoted
may be slightly optimistic because most repeated measure¬
ments were performed with phantoms, not with live subjects.
In addition some values were based on as few as three
repeated measurements and in general not more than six.
After expending such effort in designing and constructing
the various irradiation apparatuses it is unfortunate
that the precision of the techniques was not evaluated
more fully.
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1. 4 Partial Body Activation Analysis
Neutron activation analysis of specific sites in the
body has been performed either to investigate individual
organs or to measure a value that may reflect the whole
body elemental status of a patient. There are several
advantages of partial body measurements over whole body
measurements. Prom the financial aspect it is consider¬
ably cheaper to construct apparatus for partial body
measurements. Secondly, it is better to limit the patient
dose to the organ of interest ana to avoid unnecessary
irradiation of other organs, particularly those which are
more radiosensitive. It can also be more desirable to
measure changes of an element at a particular site, even
if the element is present throughout the body; for
example,where changes in calcium in the body are greatest
at sites containing trabecular bone. Finally, a patient
may find partial body measurements psychologically less
traumatic than some of the whole body measuring apparatus,
such as those at Brookhaven and Washington. The major
disadvantage of measuring the partial body content of an
element is when that element occurs throughout the body,
and hence absolute values may be difficult to obtain.
The first partial body site to be investigated by
neutron activation analysis was the thyroid, investi¬
gations being started by two separate groups at around
the same time. The workers at East Kilbride (Boday et
al 1973d) measured the total iodine content by monitoring
1 ?8
the induced I after irradiation by neutrons from their
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UTR-100 KW reactor with a maximum yield at about 1 MeV.
128
As I has a fairly low energy there was a large back¬
ground contribution to the spectrum and so the design of
the detection equipment was very important to achieve good
counting statistics. The counting apparatus used at East
Kilbride varied considerably so the accuracy of the tech¬
nique also varied.
In initial phantom and in-vitro measurements (Boddy
1966), irradiation was for 5 min and detection for 10 min
using a single 7.6 cm x 7.6 cm Nal crystal in a whole body
counter. For a dose of about 18 rem the minimum detectable
amount based on counting statistics was estimated to be
O.65 mg. For clinical studies the patient lay prone on
the top of the reactor, his thyroid positioned over the
opening of a 15 cm x 7.5 cm collimator for a 5 min period.
Counting was then performed using a shadow shield thyroid
monitor incorporating a 7.5 cm x 7.5 cm or 12.5 cm x
12.5 cm Nal crystal. Good agreement was found in two
patients whose thyroids were measured in-vivo before and
in-vitro after thyroidectomy using neutron activation
analysis (Boddy and Alexander 1967). The error due to
counting statistics and spectral stripping was about 5 to
10$, and the error due to variation in thyroid size, about
6$. In seven patients there was a poor relationship
between activation analysis and biochemical measurements
of the excised glands (Boddy et al 1968).
With an improved detection system incorporating two
crystals, a maximum variation of 14$ due to size and
position was obtained, the standard deviation being
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comparable to that for iodine levels above 4 mg (Boddy et
al 1970). The use of a boron absorber to filter the beam
was found to give better uniformity through the organ with
the effect, however, of reducing the sensitivity (Boddy et
al 1971). The final system adopted by East Kilbride for
thyroid measurements used a beam size of 15 cm x 10 cm, a
dose of 22.5 rem (Boddy et al 1969), a boron absorber and
a single 29.2 cm x 10.2 cm Nal detector. The total system
error was about 15$ (Boddy et al 1973d).
The group in Orsay also used a reactor to investigate
the measurement of thyroidal iodine but the technique
differed considerably from that used at East Kilbride.
Completely thermalised neutrons were used so the fluence
129
was inhomogenous. To correct for this, J~L was used as
129
an internal standard. The half life of I is very long
7(1.6 x 10 yr) and when it is bombarded by neutrons it
yields 15°l(Ti = 12.5 hr) and 130ml(Ti = 9.2 min) with
peaks at 540 KeV, 660 KeV and 740 KeV. On the macroscopic
127 129
scale, the distribution of I and I were the same and
129
the i did not appreciably alter the iodine content of
the gland.
Initial experiments were performed on two sheep
(Lenihan et al 1968) and good agreement was found between
the estimated iodine content and the actual values after
the thyroids had been removed. In practice, difficulty
1 *50iii
was found in resolving the 540 KeV peak of I and the
510 KeV peak associated with the annihilation radiation
from other elements (Lenihan et al 1967). Measurements
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were performed using this technique on a group of 11
patients, of which five were euthyroid and six had
endemic goitres (Rivere et al 1970).
The reactor at Orsay was also used for bone mineral
measurements of the tibia in three volunteers, one of
whom had a callous from an old fracture (Comar et al
1968). Thermal'neutrons from the reactor, after passing
through a 2 cm x 5 cm collimator, were directed against
the anterio-medial surface of the tibia. A 20 cur Ge(Li)
detector, 10 cm from the leg, was used to measure the
spectrum from thermal neutron capture during the 10 to
30 min irradiation. Three peaks were seen, 5.090 MeV and
5.598 MeV from chlorine and 5.393 MeV from calcium, al¬
though the sensitivity was very low. At the end of the
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irradiation, the induced activity from Ca, Na and
57^ CI was measured using a 20 cm x 10 cm Nal detector
surrounded by 4 cm thick lead with a 6 cm diameter
opening. The ratios Ca/Na, Ca/Cl and Na/Cl were investi¬
gated for up to half an hour after irradiation. For a
dose of 7 rem it was state.d that the reproducibility was
adequate for sequential studies.
This same reactor was used to measure the Ca/P mass
ratio using Na as an internal standard (Comar et al 1970).
The promptrays of phosphorus (77.2 KeV) and sodium
2
(90 KeV) were measured using a 1 cm planar Ge(Li) drift
detector. At the end of the irradiation the ^Ca/^Ra
ratio was calculated, hence sodium could be used as an
internal standard. The Ca/P values obtained in two
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patients were 2.9 ana 2.6. These were higher than the
accepted values, probably due to the effect of recircu¬
lation in the soft tissue. Acceptable reproducibility
figures could only be achieved by using a much larger
planar Ge(Li) detector.
Partial body calcium measurements were performed in
Toronto using Pu-Be sources (McNeill and Agard 1969, Agard
et al 1971). Pour sources, each of 5 Ci were immersed in
an aqueous medium and arranged to give a relatively uni¬
form flux in the region of the os calcis. After a 10 min
49
irradiation and 3 mm delay, the induced Ca was measured
for 10 min between two 20 cm x 10 cm Nal detectors located
in a whole body counter. Using a Rando phantom, a net
count of 1800 was obtained for a dose of 1 rem. The re¬
producibility of the method was about 4ft (McNeill et al
1970). No patient measurements were reported with this
system and the sources were incorporated in apparatus to
measure calcium in the trunk.
It was thought that partial body calcium measurements
of the trunk would have advantages over whole body mea¬
surements because larger percentage changes would occur
(McNeill et al 1973b). Twelve 5 Ci Pu-Be sources were
placed symmetrically above and below the trunk with a
source to skin distance of approximately 12 cm. Hydro¬
genous reflectors, 30 cm thick, were fixed above and
below the sources and 4 cm thick wooden premoderators
were used. The thermal neutron fluence, to the 50^ level,
covered an area 60 cm x 30 cm, so for a 6 ft subject,
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30$ of the total bone was viewed whereas for a 4 ft subject,
the figure was 60$. The variation in thermal fluence was
15$ anterior to posterior, and ±20$ along the length of
the measured region (McNeill et al 1971). Irradiation and
delay times were 20 min and 3 min, after which the subject
was counted for 20 min using four 20 cm x 10 cm Nal
detectors positioned along the mid-line. A dose of 0.4
rem was received by the patient and approximately 1000 net
49
counts were obtained from Ca. The effect of body thick¬
ness was investigated and results using an Aldersen phan¬
tom gave an error of 5$/cm body thickness (McNeill et al
1974). The overall reproducibility of the method, based
on measurements of normal volunteers, was quoted as 6.4$.
Extensive patient measurements, both sequential and
absolute, were performed using a calcium index based on
16 normals, and a correction for body thickness.
Calcium index: Counts = 207(height) + 17
Thickness = 1.46Vw/H - 6.23
(Harrison et al 1975)
Calcium measurements of the hand, which contains
large amounts of trabecular bone, were performed in
©
Aberdeen using a single 25 Ci Am-Be source (Catto et al
1973a). The source was placed inside a perspex tube with
a wall thickness of 1 cm which was in the centre of a
water tank. The perspex tube was gripped by the patient
for 1000 s after which the hand was counted between two
13 cm x 10 cm Nal detectors for 2000 s. The dose was
originally quoted as 5 rem per measurement, but this has
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since been checked and found to be 15 rem (Ettinger 1975).
Reproducibility measurements using nine cadaver hands gave
a value of C.V. = 5$ and the calcium values obtained by
neutron activation analysis compared well with the ashed
values of five of the hands. The apparatus was used to
monitor changes in patients undergoing chronic haemo-
dialysis.
A system was designed to measure the levels of
cadmium in the liver using the cyclotron at Birmingham
(McLellan et al 1975). The patient lay in a semi-prone
position and the liver was irradiated from below by a
vertical beam of neutrons which was pulsed to reduce the
background gamma radiation. The 0.559 MeV prompt gammas
were detected by a Ge(Li) detector. Phantom measurements
suggested that small variations in the patient's position
gave an accuracy to within ±5$ and a dose of 0.4 rad was
required to detect low Cd levels in the region of 0.5
p.p.m. A portable system was also developed using a
single Pu-Be source (Thomas et al 1976) which had a
relatively low gamma background. It was also found that
for considerably enlarged livers the maximum error in a
measurement was 20</°. Both methods were used to detect
toxic levels of Cd in factory workers.
The Hammersmith cyclotron was used to measure the
retention function of sodium in the hand (Spinks et al
1976a). The patient's hand was placed in a premoderator
glove and given a dose of 1.5 rad during a 50 sec irra¬
diation. The patient's hand was then measured between
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two 15 cm x 10 cm Nal detectors for 20 min at intervals
from 3 min to 48 hr after irradiation. It was found that
24
the retention function of the Na could be expressed as
two exponentials, or better still as a power function.
This retention function was then studied in patients with
a range of metabolic bone diseases.
Calcium measurements of the hand have been performed
pep
in Lyons using Cf (Guey et al 1976). The irradiation
geometry resembled that of Catto described previously. A
single 75 mCi source was used inside a perspex tube of
wall thickness 1.25 cm which the patient gripped, and
this was surrounded by 200 litres of water. After an
irradiation of 600 s and a delay of 30 s the hand was
counted for 600 s between two 15 cm x 10 cm Nal detectors.
The dose to the hand was 2 rem and approximately 4500
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gross counts were obtained in the ^Ga region. The
apparatus has been used primarily for measurements on
patients with chronic renal insufficiency.
A method for measuring both calcium and phosphorus
252
in the hand was developed using sources of Of and
Pu-Be together (Maziere and Comar 1976). Two 100 mCi
252
sources of Cf and four 10 Ci sources of Pu-Be were
arranged in a circle of diameter 12 cm. The subject's
hand entered a tube and gripped a hand grip, which was
surrounded by the ring of sources, at the centre of a
1 m cube wax block. A dose of 8 rem was given during a
5 min irradiation and after a 45 s delay the hand gripped
a rod between two 12.5 cm x 12.5 cm Nal detectors for an
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8 min and 24 min count. On phantom measurements the
statistical error was 2.5$ for P and 1.6$ for Ca and the
reproducibility from measurements on a skeletal hand was
within 3$ for both.
The first partial body measurements of the spine were
performed using the Birmingham cyclotron to measure calcium
and phosphorus (Al-Hiti et al 1976a). The patient was
irradiated sitting upright in a chair which was elevated
so that the lumbar region of the spire was level with, and
facing the target. Past neutrons with mean energy 3.5 MeV
were collimated to a 20 cm x 10 cm region of the spine and
a dose of 3 rem to the spine was given in 150 s. After a
delay of 150 s the induced activity was measured for four
5 min periods with the subject sitting upright on a seat
with his spine against a single 15 cm x 15 cm Nal detector.
Unilateral irradiation and detection could produce large
137
positional errors and to minimise this a small Cs
source was attached to the patient to correct for any
error in positioning during counting. Repeated measure¬
ments on several volunteers gave a reproducibility of
±3$ (Al-Hiti et al 1976b).
A comparison of all the techniques used for measuring
partial body calcium in patients is given in Table 1.2.
1.5 Clinical Results using In-Vivo Neutron Activation
Analysis
Neutron activation analysis has been performed on








































































either the normal level of a particular body element, the
level of an element when a patient is suffering from a
particular disease or to assess the efficacy of different
forms of treatment. Many patients, however, have also
been irradiated simply to validate' the technique of
neutron activation analysis, or a particular piece of
apparatus. Such patient measurements, or data obtained
on individual patients, will not be discussed here;
rather the emphasis will be placed on studies conducted
to obtain clinical information relevant to the treatment
of future patients. Such studies will serve as a more
valuable evaluation of neutron activation analysis.
(a) Non-Exchangeable Sodium:
Whole body sodium has been measured both by neutron
activation analysis and by isotope dilution techniques,
the latter measuring the exchangeable sodium present. In
the first whole body neutron activation measurements
(Anderson et al 1964) no evidence was found for a non-
exchangeable sodium pool. However, evidence was later
produced for a non-exchangeable pool of about 17$ by the
Birmingham group (Chamberlain et al 1968c). An even
higher value of 27$ based on results from five patients
was found in Washington (Rudd' et al 1972).
(b) Renal Disease:
Long term total body calcium measurements were per¬
formed on a group of 27 patients on maintenance renal
dialysis (Denney et al 1972, 1973). Correlation with
bone histology showed that patients with "osteomalacia"
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had the lower total body calcium (88$ of normal) and
those with fibrosis, the highest (108$ of normal).
Patients with fibrotic and histologic bone patterns
showed relatively stable calcium balance while all the
other types were negative. The dialysate bath calcium
was increased from 3 to 4 mSq.ml'and a shift was detected
towards positive calcium balance.
Absolute values of body composition were measured in
6 uremic and 11 dialysis patients using the 14 MeV
generator in Brookhaven (Cohn et al 1972b). Total body
calcium was the same as in normals in both groups. The
only significant values found were raised sodium levels
in uremic patients and losses in dialysis patients when
the latter group was followed sequentially.
Sequential partial body calcium measurements of the
hand showed a loss over 6 months on 13 dialysis patients
with dialysate calcium 5.3 to 5,.5 mg per 100 ml (Catto et
al 1973b). The mean calcium loss was 10.8$ and this was
evident in 93$ of the patients, though it must be stated
that their criterion for a significant change was one
greater than 1 S.D. Radiological change was noted in
only 15$ of the patients.
Total body calcium was measured in 14 unselected
cases of chronic renal insufficiency, none of whom
required dialysis (Hosking et al 1973). Total body
calcium fell in patients with osteomalacia but this change
could be reversed with pharmacological doses of vit. D.
In those with osteitis fibrosa, total body calcium
increased.
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In 13 patients with modest to severe renal insuffi¬
ciency, an effort was made to correlate total body values
measured by neutron activation analysis with clinical
measurements (Letteri et al 1974). Total body calcium,
expressed in absolute terms or as a function of lean body
mass, did not correlate with creatinine clearance
(glomerular filtration rate), plasma HCO^ or plasma Ga.
However the total body P/Ca ratio was increased in eight
out of ten patients with G.F.R. < 20 ml.min'and all
patients with plasma P > 6 mg/100 ml had an increased
P/Ca ratio.
Partial body calcium measurements were carried out
in Toronto on 36 patients less than 55 years old with
renal failure and the patient's "bone index" (B.I.) was
determined (Harrison et al 1974a). Seventeen had a B.I.
below normal, seven of these having no evidence of renal
osteodystrophy. Eighteen had a normal B.I. but ten of
these had moderate or severe renal osteodystrophy. One
had a high B.I. with no evidence of bone disease.
Hollowing treatment with vitamin D some patients with
renal osteodystrophy increased their B.I. by 20fo - 25
to normal or above normal values.
The effect of 1-<Y-hydroxy cholecalciferol, a vitamin
D analogue, on renal osteodystrophy was monitored both by
whole body and part body activation analysis and will be
discussed in detail in Chapter 7.
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(c) Osteoporosis:
The effect of treatment of osteoporosis has always
been difficult to assess because any changes so small.
The fact that small changes can be detected over a fairly
short period makes neutron activation analysis the ideal
method of monitoring the treatments of osteoporosis.
Whole body calcium was measured in seven patients
over a period of 3 months during which time they were
treated with porcine calcitonin together with dietary Oa
and P supplements (Cohn et al 1971b). After this time,
three of the patients had increased their Ga by amounts
greater than 1.9$, the precision of the technique. The
lack of a control group and the fact that only three
patients responded makes the study inconclusive.
The same technique was used on eight patients before,
and 2 to 7 months after, treatment with fluoride (Gohn et
al 1971c). No significant increase was recorded in any
of the patients, though over such a short time period and
in such a small group this is perhaps not a conclusive
result.
The group in Washington performed whole body measure¬
ments for longer periods. Five women with idiopathic
osteoporosis were given a series of intravenous calcium
infusions for between 12 and 15 months (Dudl et al 1973).
No patient showed improvement and the loss of total body
calcium was similar to untreated osteoporosis.
The same apparatus was used on 26 postmenopausal
osteoporotic females to test the effect of dianabol
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(Chestnut et al 1974, 1975). The patients were divided
into two groups of thirteen; one group receiving 5 mg
dianabol and the other a placebo. Six patients on
placebo and ten on dianabol completed the two year study
showing a significant decrease (3.1$, p< 0.005) in total
body calcium in the former and an increase (2.0$, p<0.10)
in the latter. The difference between the two groups was
found to be very significant (p<0.0l).
Seven patients with Cushing's syndrome were monitored
before treatment and all except one was treated surgically
(Aloia et al 1974). Pour of the patients were followed
for up to 25 months and two of these exhibited a signi¬
ficant increase in total body calcium following therapy.
These patients were however aged 14 and 21, so the
increase could be due to growth rather than the reversing
of the osteoporosis following the correction of hyper-
cortisolism. The mean total body P increased to a great
extent post-operatively.
(d) Parathyroid Dysfunction:
Ten cases of primary hyperparathyroidism were studied
for up to two years in Birmingham (Hosking et al 1972a).
Seven of the cases had successful surgery but the response
to parathyroidectomy was variable. No correlation was
found between post-operative changes in calcium content,
parathyroid size and histology, nor with the mode of
clinical presentation. It was suggested that absolute
measurements would be of more use, as any decreases may be
due to a return to the normal calcium level.
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Absolute levels of Ca and. P were measured in nine
hyperparathyroia patients, eight'of whom were untreated
and in three hypoparathyroid patients using whole body
activation analysis (Cohn et al 1973e). In the patients
with hyperparathyroidism, three were within the normal Ca
range and six had a mean calcium 85$ of normal. A low
mean value of P/Ca was found - consistent with PO^ loss.
In the three patients with hypoparathyroidism, the bone
calcium levels were raised as would be expected.
(e) Osteomalacia:
In Toronto, part body calcium measurements were per¬
formed on four patients with active osteomalacia and an
increase of 30$ after 2 to 6 months on treatment was
reported (Harrison et al 1972, McNeill and Harrison 1973a).
Calcium measurements, normalised using the subject's
height or arm span, were performed on seven fully grown
patients with familiar hypophosphatemic vitamin D refrac¬
tory rickets (Harrison et al 1976). In the five patients
with rachitic deformities the calcium bone index was above
normal (p<0.002). In contrast, the two without were in
the normal range.
Changes in total body calcium and sodium were
measured on six patients receiving different treatments
for osteomalacia (Hosking et al 1972b). Each patient
showed an increase of between 3$ and 30$ though only four
patients were studied for the complete 24 months. In
these patients the increases occurred for the whole period,
though complete healing had occurred after 6 months on the
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basis of histological examination. In general, as the
calcium rose, there was a fall in the non-exchangeable
sodium pool in the bone.
Whole body calcium measurements were performed on
thirty chronic alcoholics, eighteen with cirrhosis and
twelve without, to investigate the reported decrease in
bone mass caused by possible vitamin D deficiency due to
cirrhosis of the liver. Both total body calcium and bone
mineral content did not show any loss in either group of
patients (Roginsky et al 1976).
(f) Paget's Disease:
Twenty patients were treated with calcitonin and
whole body calcium measurements were performed (Wallach
et al 1975). Despite clinical improvements, seven out of
the fifteen who completed the study showed partial or
total loss of the initial decelerating effect of calci¬
tonin on skeletal turnover, whereas the remaining eight
maintained it. Changes in the skeletal turnover were
roughly proportional to changes in alkaline phosphatase
and urine hydroxyproline. The mean total body calcium
was raised by 22i<> compared with normals prior to treat¬
ment and after treatment the mean was decreased by 4$,
the change being significant.
(g) Acromegaly:
Whole body Ca, Da, CI, P, N and K were measured in
ten patients (Aloia et al 1972). Total body calcium was
raised in all but two and in some cases strikingly so.
The ratio Ca/K was decreased in all cases and the observed
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changes in K, N, Na and P were similar to those produced
by chronic administration of growth hormone to normal
subjects.
(h) Cadmium Toxicity:
The partial body measurement of cadmium in the liver
has proved very effective in detecting quantities absorbed
by industrial workers. The level in patients was found
to be between 0-2 p.p.m. whereas the levels in works
"at risk" were between 35 p.p.m. and 200 p.p.m. (Harvey
et al 1975).
1.6 Comparison of Neutron Activation Analysis and
Densitometry
The method of measuring bone mineral content using a
photon absorption technique (Cameron et al 1963) is widely
used. As its main function is to monitor calcium loss,
it is important to compare it with neutron activation
analysis.
Whole body activation analysis was compared with
densitometry at six sites of the radius, ulna and humerus
(Chestnut et al 1973a, 1973b) in fourteen osteoporotic
patients. There was good correlation at all six sites,
the correlation coefficient ranging from r = 0.94 to
r = 0.84. When, however, both the methods of measurement
were normalised, the correlation was much worse; r = 0.79
at the site where previously .r = 0.94 (Manzke et al 1975).
In Brookhaven, whole body calcium was compared with
densitometry of the radius 8 cm from the distal end, in
-44-
six different patient groups including normals. The
correlation coefficients ranged from r = 0.826 for the
osteoporotic group to r = 0.973 for normals (Cohn et al
1973d). The values from the forty osteoporotic patients
were normalised, total body calcium with and the bone
mineral content with the width of the radius. Correlation
then became r = 0.454 (Cohn et al 1974). Thirty-four of
these patients, most having vertebral compression frac¬
tures, were studied over an interval of about 9 months.
Most patients displayed a change in total body calcium
and bone mineral content that was at least twice the
precision of the method. No correlation was found
between the changes measured by both methods (r = 0.17)
(Aloia et al 1975). A similar trial was carried out with
twenty-five patients with severe chronic renal failure
and fifty-three patients with severe uremia who were on
dialysis (Cohn et al 1975, 1976). Correlation coeffi¬
cients of r = 0.919 and r = 0.892 were obtained on the
two groups respectively, when absolute measurements were
compared. However the correlation between changes over
a time period in all seventy-eight patients was poor
(r = 0.25).
Comparisons between partial body calcium content and
densitometry have not been made so thoroughly. The
calcium content of the trunk was compared with densito¬
metry of the radius in seventy-one individuals and a
correlation coefficient r = 0.76 was obtained. Twenty-
seven patients were also measured sequentially to compare
the changes measured by both methods. "Reasonable
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agreement" was obtained in twenty-one out of twenty-
seven and a marked discrepancy in three cases (Harrison
et al 1974b).
Densitometry of the same site was compared with
activation analysis of the hand in thirteen dialysis
patients (Catto et al 1973b). The mean calcium loss was
10.8$, evident in twelve patients whereas the mean
mineral loss was 3.8$, evident in seven patients. Unfor-
i
tunately no correlation figures were given.
A good correlation was obtained between activation
analysis and densitometry results in all the studies
simply because the stature of the patient was reflected
in both measurements. Thus when the effect of size was
reduced by normalisation, the correlation was worse. The
most important results were the correlations between the
changes measured by both methods. The poor correlations
that were obtained still leave two major questions un¬
answered. Firstly, does neutron activation analysis of
calcium measure the same thing as densitometry and
secondly,even if it did, would changes in the radius
reflect changes in the overall calcium status of a
patient? Before answering the second question an effort
must be made to answer the first. An attempt is made
in this thesis by performing neutron activation analysis 7







Two sources of Californium -252 were used for the
neutron activation analysis measurements. Californium
-252 produces a typical fission neutron spectrum (Pig.l.l)
which can be represented by the Watt formula:-
N(E) = 0.373e "°-88E sinh (2.0E)^
where N(E) = fraction of neutrons/unit energy range
and E = energy in MeV
252
The mean energy of Cf is in the region of 2.35 MeV
(Meadows 1967) and it decays with an effective half life
(alpha and spontaneous fission) of 2.65 years (Amersham).
o
Its high specific neutron emission, 2.3 x 10 neutrons,
sec-'!" mg-\ means that sources used for patient irradia¬
tions can be very compact. The relatively low mean energy
makes it an ideal radionuclide source for partial body
measurements at peripheral sites of elements activated by
thermal neutrons.
252
The two sources of Cf arrived at the Western
General Hospital in January 1975, each of activity
approximately 51 mCi. The sources had previously been
used for about 3 years at the Scottish Universities
Research and Reactor Centre (S.U.R.R.C) in East Kilbride
where some of the initial physical evaluation was performed.
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252
The ideal Cf source activity for patient measure¬
ments was stated as being 200 mCi (Boddy et al 1974b)
while a feasibility study carried out in America stated it
to be between 500 mCi and 1500 mCi (Evans et al 1976).
252
However the half life of C'f meant that our patient
measurements would have to be performed with a total com¬
bined source activity eventually as low as about 50 mCi,
so the system was designed accordingly. In fact, it was
possible to replace the sources in March 1977 with two
sources each of activity 104 mCi, which were purchased to
extend the existing studies over a longer time period and
to enable partial body measurements of the lower spine to
commence.
2.2 Irradiation Chamber
The room constructed for patient irradiation was
situated in the basement of the hospital, in what was
originally the blank end of a corridor, about 20 m from
the room containing the counting apparatus. An L-shaped
baffle was constructed from concrete blocks and paraffin
wax from floor to ceiling (Pig. 2.1), to provide shielding
for the operator and other hospital personnel. In addition,
one outside wall had to be thickened with an extra layer
of concrete blocks to reduce the dose on the outside of
the hospital. A layer of wax blocks, between 6 and 8
inches thick, was also placed in the ceiling space above
the inner section of the chamber to reduce the dose to the
casualty ward directly above. The fire safety officer was
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Figure 2.1
Scale diagram of activation chamber
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informed of the wax in the ceiling space and he was of
the opinion that it did not constitute a fire hazard.
The neutron and gamma dose was measured, using rem
counters, with the sources in the "•worst" position, that
is with no reflector of premoderator round them. The
dose levels were less than 1 mrem.hr-"'" at the operator
position and less than 0.3 mrem.hr-"'" at floor level in
the ward above.
The two sources were stored 3 m below ground when
not in use and could be delivered pneumatically to the
chosen irradiation position above ground (Fig. 2.2). This
pneumatic delivery system was developed at S.U.R.R.C. in
East Kilbride for the cylinders encapsulating the sources
(Glaros 1975). The motor and air cylinder were stored
under the work surface behind a false wall and two poly¬
thene air tubes passed through the shielding wall and
down the storage hole. The source cylinder delivery tubes
were made of strong polyethylene with a metal cap at the
end with holes in to allow the air to escape. The sources
could be delivered swiftly to the irradiation position
and back again when required with little or no error in
timing. Inductance coils were designed originally as part
of the system at East Kilbride to monitor the position of
the sources and to control the timing. These proved un¬
workable, and as the sources gave an audible click when
they reached the irradiation position and a rush of air
when they left, it was easily possible for the operator to
time the irradiation to within 0.5 s with a stop-watch.








for patient irradiation times of less than 1 min, which
is much shorter than that which was actually used.
A geiger counter was fixed inside the activation
chamber with a remote control box by the operator position.
A green or red light on the box acted as a safety device
to check that the sources were in the safe position below
ground before the operator entered.
During the two and a half year period since the
sources were installed, neither of the two personnel
concerned with patient or research experiments received
any measurable neutron dose, as detected by both fast and
slow neutron film badges.
2.3 Partial Body Irradiation Sites
As far as neutron activation analysis is concerned,
the element that is of most clinical interest is calcium
in the bone. Careful consideration had to be given to
achieve the optimum patient irradiation geometry at the
most suitable body site. Although regions such as the
spine are of great clinical interest it was decided to
commence activation measurements at a peripheral site
whilst a method for spine measurements was being developed.
Out of the four main peripheral body regions, the forearm
was chosen as the most suitable site for the majority of
patient studies. This is not to say that the forearm is
superior in all respects to the other sites but rather
that it offered the best compromise of the following
characteristics
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The quantity of calcium present. As the isotope of
A Q
calcium which becomes activated, Ga, is only
0.186$ abundant, the body site chosen must have
sufficient calcium present to achieve adequate
counting statistics. The approximate percentage
of the skeleton in the peripheral sites is 2.68$ in
the radius and ulna, 1.52$ in the hand and wrist,
6.33$ in the tibia and fibula and 5.82$ in the foot
(Spiers and Burch 1957). However, because of the
size of the different regions, the efficiency of
activation and detection multiplied by the amount
of calcium present, gives a comparable number of
calcium counts in all four regions for a given dose.
Uniformity and size of the bone. The long bones of
the forearm and lower leg are the most uniform and
so would probably give better precision results with
bilateral irradiation. Also the wider the bone, the
greater the non-uniformity of thermal neutron flux
through the bone and hence the precision would be
worse.
The likelihood of calcium changes occurring. Calcium
changes in response to treatment may be expected to
occur most rapidly in regions of trabecular bone.
The distal end of the radius and the carpals in the
hand are mainly trabecular bone as is the os calcis.
The os calcis, however, has been shown to lose
calcium during periods of bed-rest, a complication
which may affect any study being performed over a
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long time interval.
Quantity of overlying soft tissue. Induced acti-
38
vation of elements such as CI and particularly
^Na will interfere with the measurement of ^Ca.
The hand and foot have the least overlying soft
tissue but not a great deal less than the forearm,
which in turn generally has much less than the
lower leg.
Likelihood of changes in the bone structure. Changes
in bone shape due to accidents etc., are probably
more likely to occur in the foot and hand.
Ease of positioning. For both irradiation and
counting, the region must be completely immobile in
a comfortable position for the patient. It was
thought that this could more easily be achieved in
the case of the forearm which could be strapped
into an arm-shaped mould with little discomfort for
the subject. A region such as the hand would be
the most difficult to immobilise.
Comparison with other techniques. The main test
which activation analysis must be compared with is
bone densitometry by photon absorption. This test
is performed on the radius and as yet no direct
comparison has been made between the two methods
at the same site.
Absolute calcium measurements. Although the emphasis
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of the work has not been towards absolute calcium
determination, it was felt that if the measurements
were required to be normalised, then the long bones
of the forearm would probably offer the best chance
of success.
2.4 Premoderator Thickness
The function of the premoderator is essentially to
"slow down" the neutrons and consequently it performs two
functions. The first is to increase the thermal neutron
flux and the second to reduce the dose,, the largest pro¬
portion of which would come from fast neutrons. In the
techniques available where the patient's hand gripped a
tube containing the neutron source (Catto et al 1973a,
Guey et al 1976), the thickness of premoderator was
chosen to give the maximum thermal flux. In the first case
the dose was fairly high, around 15 rem for each measure¬
ment. In our design of the irradiation apparatus the
premoderator thickness was chosen not to maximise the
thermal flux but to optimise the value of calcium counts
per unit dose to the bone.
Gold foils were used to measure the thermal flux.
The foils were each approximately 1 cm in diameter and
0.0025 cm thick and weighed about 40 mg. The foils were
made from a sheet of gold foil using a cork borer and each
one was numbered and weighed. After activation they could
be measured easily in an automatic gamma sample counter.
It was not convenient to use Mn, the activation
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cross-section of which is similar to calcium, or Na,
because both these methods would require fairly bulky
targets. They are suitable for large sources of a high
neutron output, but when a point source 0 to 15 cm away
is to be used, their large dimensions would produce
errors.
The unavailability of any thermal neutron absorber
prevented any correction being made for the epithermal
resonances of gold. As the contribution from these would
be small and as relative measurements were being performed,
it was felt that any error would be minimal.
In addition to thermal flux measurements, the
variation in activation of a long bone was simulated using
an extended source of NaOH in a perspex tube 30 cm long
and 0.8 cm diameter. The induced activity was measured
at the centre of a whole body counter by four 15 cm x
10 cm Nal detectors.
The variation in activation and dose with different
thicknesses of perspex premoderator is shown in Figure
2.3. By combining the extended sodium source curve with
the dose curve (see Section 2.6) in Figure 2.3, curve (l)
was obtained in Figure 2.4, which represents the dose per
unit activation. It can be seen that there is no minimum
on this curve, though the decrease in slope begins to get
less with more than 9 cm premoderator. These low values
of dose per unit activation, however, could only be
achieved with longer irradiation times and with induced
activities which have a half life much greater than the
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Using the available Cf sources the irradiation
time was comparable to the half life of the induced ^Ca,
and hence the small values of dose per unit activation in
curve (1) (Fig. 2.4), could not be achieved.
With 8 cm of premoderator,experiments using a skeletal
arm showed that during a 10 min irradiation sufficient
counts could be obtained (approximately 5000 to 3000
over a 2 year period). Using this information, the irra¬
diation time required to obtain the same number of counts
with different premoderator thicknesses was calculated.
The dose per fixed count was then calculated and is shown
plotted against the different premoderator thicknesses in
curve (2) in Figure 2.4. From this, the optimum pre-
252
moderator thickness, for the available Gf source
strength, was found to be about 7.5 cm.
2.5 Patient Irradiation Apparatus
In the design of the irradiation apparatus the limb
and the sources had to be surrounded by a form of reflector
to increase the thermal fluence through the patient's
limb. A hydrogenous material such as paraffin wax or
water was most suitable and in addition to reflecting
some of the neutrons back through the limb, it also acted
as a shield for the more sensitive regions of the patient.
Hydrogenous reflecting material was also required around
252
the limb with the available low strength Cf sources,
to increase the thermal flux through the bone. Tests
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showed that about 9 cm of reflector was the minimum thick¬
ness required above the limb to give maximum reflection,
though in practice more would be desirable to reduce the
dose to the rest of the patient.
For the main studies to be performed on the forearm,
two different irradiation geometries were used. The
first irradiation geometry, geometry A, was used on
patients undergoing chronic haemodialysis, the first large
patient group to be studied.
In the design of the apparatus for measuring this
patient group, consideration had to be given to possible
problems that were characteristic to patients on dialysis.
The first was the risk of infection from hepatitis.
Several of the patients in the study had survived the
hepatitis outbreak in Edinburgh in the early seventies
and so could have hepatitis antigens. As it was proposed
to measure the forearm containing the shunt, as well as
the other arm, it was felt that immersion in a water bath,
a possible method of moderating and reflecting the neutrons,
would be undesirable. Any such water bath would contain
a fairly large volume of water and the logistics of per¬
forming a large number of patient measurements made
changing the water and sterilising the bath not feasible.
The second problem was that swellings in the shunt arm
could occur. Any such swellings would usually occur at
the site where the needles were inserted, so room was left
between the arm and the reflector to allow for any such
eventuality.
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The apparatus for irradiating the forearms of the
renal patients is shown in Figure 2.5. The source delivery
tubes were positioned inside 30 cm diameter by 20 cm deep
cylindrical wax reflectors. Attached to the cylindrical
wax reflectors were perspex premoderators. As 7.5 cm had
been found to be about the optimum thickness of moderator,
semi-cylindrical premoderators of radius 6 cm were used,
allowing for an overlying soft tissue thickness of 1.5 cm.
The forearm rested on a perspex support and was
positioned using a hand grip and canvas straps with
"velcro" fasteners. The forearm support was attached to
a wax reflector block 29 cm long, 16 cm wide and 28 cm
high below the arm. Above the arm, resting on the tops
of the premoderators, was another wax reflector block
30 cm long, 19 cm wide and 12 cm high.
Both of the source/premoderator/reflector assemblies
could move with respect to the forearm support and thus
the centre of irradiation and the separation between the
premoderators could be varied. In actual fact a separa¬
tion distance of 7.75 cm between the premoderators was
used throughout with the centre of irradiation a distance
of 19.5 cm from the centre of the hand grip.
In Figure 6.1a the apparatus can be seen with a
subject's arm in place, the upper wax reflector being
removed for the purpose of the photograph. The subject
sat on an adjustable chair in a comfortable position with
the arm horizontal from the shoulder. In such a position
the patient was unlikely to move and the rest of the body




IrradiationgeometryAusedf rre alpati nts
The region of bone that was activated and the varia¬
tion along and across the bone is shown in Figures 2.6
and 2.7. To measure this, gold foils were positioned in
an arm phantom 33.5 cm long, 7.5 cm high and 4.5 cm wide
made from perspex. The full width at half maximum
(F.W.H.M.) of the thermal fluence was 21.6 cm and the 0
variation across the central 5 cm was l3-3°/o at the
centre.
In September 1976, measurements were started on more
patient groups in addition to the renal patients. By
252
this time the total Cf activity was 66 mCi and to
/ O
increase the activation of Ca in the forearm, a new
irradiation geometry, geometry B, was designed and con¬
structed .
The cylindrical wax reflectors, into which the
delivery tubes went, were still used. However, the per¬
spex premoderators and the upper and lower wax reflectors
were replaced by a large water bath (Figs. 2.8, 6.1b).
The tank was made of 1 cm thick perspex and the outer
width was 17.0 cm. The water acted as a combined pre-
moderator and reflector, the neutrons being moderated by
about 7.5 cm of perspex/water/soft tissue before reaching
the bone. The forearm rest was constructed diagonally at
an angle of 45 degrees and the arm was held rigid using a
mould of butyrate, the material used for radiotherapy
moulds, and a perspex hand grip. The forearm mould was
sufficiently elastic to fit any size of forearm, and
"velcro" fasteners prevented any vertical movement. An
-64-
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immersion heater could be fixed to a crosspiece at the top
of the tank and this was used for a short time each morning
to slightly warm the water. Savlon was used in the water
as an antiseptic and the water was regularly changed each
week.
It was hoped that the elimination of any air gap
around the forearm would not only increase the sensitivity
of calcium activation but would also eliminate the varia¬
tion in activation from patient to patient caused by
differing amounts of soft tissue as was found in the renal
patients. This would be important if at any stage it was
decided to try and obtain absolute levels of the bone
calcium.
The variation of thermal fluence was measured the
same way as for the other irradiation geometry and the
curves of variation along and across the bone are shown
in Figures 2.6 and 2.7. The F.W.H.M. was less using the
water bath, 16.2 cm, than with the first irradiation geo-
pep
metry due to the Cf being closer together, (17 cm
separation as opposed to 19.75 cm). The sensitivity of
activation of irradiation geometry B over the central
25 cm region was an improvement over geometry A by a
factor of 1.8.
2.6 Dosimetry Measurements
The dose received by patients was determined experi¬
mentally using apparatus that was kindly loan by Dr. R.
Lawson and Dr. D. Porter from the Department of Clinical
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Physics and Bioengineering in Glasgow. The experiments
were performed in early April 1975 when the source activi¬
ties were each approximately 48 mCi.
The neutron plus gamma dose was obtained using gas
flow polythene-ethylene ionization chambers, one being
cylindrical and one a parallel plate device. The cylin¬
drical chamber, diameter 1 cm and length 1.7 cm, is
described in a N.P.L. report (1974) and is based on a
design by Greene (197T). This was used for the principal
dose measurements at the position of the bone. The
parallel plate chamber (Law et al 1974) was used to mea¬
sure the.dose to the gonads and to the eyes.
The gamma dose measurements were made using a Geiger
counter surrounded by graded absorbers to flatten its
response to low energy photons (Wagner and Hurst 1961)
and also "^B plates to remove thermal neutrons which
would have had an effect on the dosemeter. The dimensions
of the working end of the Geiger counter were 2.5 cm long
and 1.6 cm diameter.
The dose was calculated at the centre of a water-
filled cylindrical phantom 7.75 cm in diameter with a
source separation of 25 cm and 6 cm premoderation. Ethy¬
lene was slowly passed through the ionization chamber and
the charge was measured. The chambers had been calibrated
C. r\
previously using a Co therapy set so the neutron dose
was calculated from the following equation:-
D ft) P W X S
ts/.\ c n n n n t\ t ±.\Dfi(t) = q X X X X X - DvAt)
q, K Sn «c c c c c
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where t refers to tissue, c cobalt and n neutrons. After
calculating the kerma ratios, the total dose to the bone
could be expressed in rads. Further explanation of this
equation and other mathematical details are given in
Appendix I.
The gamma dose in rads was obtained by combining the
252
calculated Cf gamma spectrum at the centre of the water
phantom with the response of the geiger counter with
energy. Thus, after including a correction for dead time,
a r
a value for rad.count" was obtained.
The results of the dosimetry measurements at the
position of the bone were 0.0185 rad.min"^ from neutrons
and 0.0177 rad.min"^" from gamma radiation. From these
figures the dose to the bone in rad.min"^" was calculated
for the two forearm irradiation geometries A and B which
had source separation distances of 19.75 cm and 17 cm
respectively. The dose to the skin was estimated using the
data in Figure 2.9 (Krishnaswamy 1972, Colvett et al 1972,
Windham et al 1972), assuming a tissue thickness of 2.5 cm.
To calculate the dose in rems to the skin surface and
to the bone, the mean R.B.E. was calculated for a cali¬
fornium spectrum after 6 cm and 8.5 cm premoderation. The
californium spectrum at intervals of 1 cm was calculated
from the original spectrum (Amersham 1972) using the
equation:-
-(NtAj + N Cf + NO" ) x


















where v = neutron energy
N = no. of atoms of hydrogen, oxygen or
carbon
0" = total neutron cross-section at neutron
energy vQ
x = distance through premoderator
the values of the total neutron cross-sections at
different energies given by Hughes and Harvey (1955).
The spectra at 6 cm and 8.5 cm were then combined with
the variation of R.B.E. with energy (N.C.R.P. 1971) using
the equation:-
where n is the number of neutrons at energy E. The mean
R.B.E. after 6 cm and 8.5 cm premoderation was found to
be 7.75 and 5.89 respectively.
The doses to the skin and bone for a total source
strength of 96 mCi are given in Table 2.1. The dose
averaged over the forearm, given during a single measure¬
ment of a patient during the period of the clinical
studies, is shown in Figure 2.10.
With a total source strength of 96 mCi the dose to
the gonads and eyes was less than 0.002 rem.min-"1" using
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Two other methods were investigated to measure the
neutron dose but both proved unsuitable because of the
low dose rate. The first was the use of discs of EeSO^
solution which were the same size as the parallel plate
ionization chamber. Experiments were performed with the
sources separated by 24 cm, a 6 cm premoderator in front
of each and a stack of 12 discs in the middle. The true
dose measurement at each disc position was measured with
the parallel plate chamber and it was hoped to combine
this with the measured changes in optical density of
2R?
EeSO^ to calculate the G value for Gf. Unfortunately
after irradiating the EeSO^ for 4 days the optical
density had only changed from 69617 to around 925 which
did not allow G to be calculated with sufficient accuracy.
In addition, even if the G factor were known, subsequent
dose measurements would have to be performed over time
periods of about 1 week which would be impractical.
The second method to be investigated was the
-74-
detection of fast neutron induced fission fragments from
^^Np (Cross et al 1975). An attempt was made to measure
these using Macrofol polycarbonate foils which were sub¬
sequently etched and viewed under a microscope. The
density of tracks was so low as to make it unsuitable







3.1 Detectors and Shielding
To measure induced activity at partial body sites, a
purpose built counter had to be designed and constructed.
Although calcium measurements of the forearm were the
dominant interest, the partial body counter was designed
to be as versatile as possible to enable it to be used
for measurements of the lower leg and thyroid, in addition
©
to the forearm. Also included in the specifications, but
not of prime importance, was the ability to measure large
urine samples in 2 litre containers and also whole body
measurements of small animals such as rats.
The basic design consisted of two Nal(Tl) detectors
each mounted inside lead cylinders which were mobile on a
large steel table. The two detectors could be used on
their own or in conjunction with a large central shield
or a thyroid collimator, the latter being bolted onto the
front of the table. Bilateral detection was considered to
be the best geometry to reduce positional errors.
The detectors used were two Quartz and Silice
"Scintiflex 152 YEE 102". The size of the Nal crystal
was 15.2 cm x 10.2 cm and the overall length of each
detector, crystal plus photomultiplier tube, was 41 em.
The detectors had to be modified slightly to change the
position of the potentiometer and input/output socket from
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the side of the aluminium casing to an insert in the base,
care being taken to keep all joints light tight.
Each detector was enclosed in a lead cylinder which
was cast in five sections to follow the outline of the
detector as closely as possible (Pig. 3.1). By following
closely the contours of the detector, the weight of lead
could be kept to a minimum whilst ensuring a thickness of
at least 6.5 cm shielding all around the crystal. Although
the background at 3.10 MeV (the region of the calcium
photopeak) was very low, this thickness of lead was con¬
sidered necessary to reduce the relatively large back¬
ground peak at 2.60 MeV from thorium decay products. The
lead used in all the shielding was monitored for contami¬
nation, whilst in the form of ingots, before it was cast
into sections. The lead enclosed detectors were supported
on small trollies with wheels at the front, which could
easily be manoeuvred using a simple lever jack pivoted on
strong wheels.
The central shield, into which the two detectors could
be positioned, is shown in Figure 3.2. Again the design
was such as to ensure a 6.5 cm thickness of lead around
the crystal, excepting the limb entrances. For forearm
measurement, the limb was placed inside the central shield
on a perspex arm rest with the two detectors either side
separated by 9.0 cm. Longitudinal movement of the arm was
prevented by means of an adjustable hand grip and trans¬
verse movement by means of a butyrate mould shaped to fit
closely round the forearm. When not in use the central
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wheeled levers previously described. If the central
shield was required for counting large urine samples, the
containers could be placed inside through the holes into
which the detectors were placed. Whole body rat measure¬
ments were also performed with the apparatus using the
perspex arm rest but with the plastic arm mould removed.
A photograph of the partial body counters is shown in
Figure 3.3.
For measurements of the thyroid, a double collimator
could be bolted onto the front of the table and the two
detectors fitted into it at an angle of 90° (Fig. 3.4).
The front of the thyroid collimator extended over the edge
of the table so that the patient could easily sit with his
neck close to the collimators and without his chest
touching the table. The collimator each side was tapered
to an outer diamter of 13 cm at the front in order to fit
fairly comfortably between the chin and clavicle. The
shape of the collimator was designed to reduce the measured
activity from regions other than the thyroid. It was
proposed to construct a small movable lead wall to place
behind the patient's neck but this was not done as thyroi¬
dal iodine measurements were found not to be feasible
because of the low source strength (Appendix II).
The weight of the lead shielding used in the partial
body counter was as follows: each detector shield - 220 kg;
the central shield - 310 kg; the thyroid collimator -
50 kg. To support this weight, the table that the detec¬
tors moved on was made of half-inch steel plate supported





legs. A small metal bar was welded onto the edge of the
table to form a "lip", so preventing any of the apparatus
from being wheeled off the table. The dimensions of the
table were 182 cm by 91.5 cm and height 84 cm.
3. 2 Electronic Equipment
A block diagram of the electronics linked to the two
detectors is shown in Figure 3.5. A single cable carried
the E.H.T. and signal through the lead shielding, from
the photomultiplier assembly to an emitter follower which
was attached to the rear of each detector shield to mini¬
mise the distance travelled by the combined signals. From
each emitter follower two leads were connected to a 'RIM
BIN' which contained the E.H.T. supplies, mixer and ampli¬
fier. It was found that when the detectors were operated
at their recommended voltages, their response was non¬
linear at energies above 2.5 MeV. This problem was cured
by lowering the E.H.T. voltage to around 1050 volts and
at this voltage, linearity was achieved up to 3.5 MeV.
Having set the voltage, the rear section of the detector
shield was removed and the potentiometer adjusted to give
optimum resolution for the two detectors at 2.75 MeV.
A consequence of the lowered E.H.T. voltage was the
tendency for the gain to vary, i.e. the positions of the
peaks would drift. Special care was therefore taken and
24
the detectors were calibrated twice each day using Ha
and ^Co sources.
The signal from the amplifier was fed into a 1024
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channel multichannel analyser. These 1024 channels could
"be divided into sub-groups and for most measurements the
background spectrum was stored in 512 channels and the
patient spectrum in the rest. The background could be
subtracted from the patient spectrum, integrations per¬
formed and an output of the required section of the
spectrum obtained on a teletype or paper tape for computer
processing.
Q>
3.3 Background and Counting Efficiency
49
The low activity, and in the case of Ca, the short
half life of the induced radiation, required the efficiency
of measurement to be kept as high as possible while keeping
the background low to achieve adequate counting statistics.
The background spectra between 0 and 4 MeV are shown in
Figure 3.6 for different detector arrangements.
The efficiency of the two detectors in the central
shield with 9 cm separation was 31$ at 2.75 MeV. The
background count rate between 2.9 MeV and 3.3 MeV was
approximately 0.09 counts per second (c.p.s.). The back¬
ground in the calcium photopeak region did not increase
greatly if the central shield was removed (0.15 c.p.s.,
12 cm separation) but the background peak at 2.6 MeV
increased approximately six-fold.
The background peak at 2.60 MeV which would inter¬
fere most with calcium measurements was monitored over
periods of 1000 sec for 48 hours to test for any variation.
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being purely statistical.
With the thyroid collimators and a lead "shadow
shield" wall behind the patient's neck, a background of
5.8 c.p.s. was obtained between 4-00 KeV and 500 KeV.
3.4 Variations in Counting Sensitivity
To obtain good reproducibility of measurement the
variation in counting sensitivity across the region being
measured must be kept to a minimum. With bilateral irra¬
diation there was little variation over the central 5 cm;
+6io and 15.8i<> with separations of 9 cm and 12 cm (Pig.
3.7). The variation in sensitivity with the central
shield along any bone that was measured is shown in Figure
3.8. The F.W.H.M. was 21.8 cm which was similar to the
irradiation profile and the product of the curves is
shown in Figure 3.9, illustrating the region of the limb
that would be measured. Isocount lines for bilateral
irradiation with the central shield and for the thyroid
collimator are illustrated in Figures 3.10 and 3.11
respectively.
3.5 Optimum Counting Time
The short half life of ^Ca meant that as the detec¬
tion time was increased, so the percentage contribution to
the gross counts in the calcium region from the background
increased. Therefore an optimum counting time existed to
give the minimum statistical coefficient of variation, for
different source strengths and irradiation geometries.
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The variation in the statistical coefficient variation
(C.V. ) with counting time was obtained from the
following equation.
Now, if in the calcium range:-
N~ = no. of detected calcium counts after time T
Ca
" » sodium " " " "
Na
NBgd = " " " bgd 11 » " "
At variable time t
(1 - e~Xt)
No. of calcium counts = x N~
(1 - e"AT) Ca
No. of sodium counts = N^a x t/T
No. of bgd counts = N-ggdx t/T
49
where A = decay constant for ^Ca.
C.V. at variable time t
s
(1 - e"xt) HCa + %at ^ NB dt
(1 - e~^T) T T
C.v = — —— x 100
(1 - e AZ) 'Ca
(l - e~^)
The variation in C.V. with irradiation time for
typical values is shown in Figure 3.12. A counting time
of 1000 s was chosen for patient measurements because after
this length of time, a sufficiently low statistical C.V.
was obtained. Extending the counting time would only
marginally reduce the theoretical statistical error and
the patient would become progressively more restless.
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Figure 3.12
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Having obtained a spectrum of the induced activity,
4-Q
the number of counts due to Ca alone must be determined.
When performing such an analysis, consideration was given
to possible interference from the following sources:
(a) Counts in the ^Ca photopeak region from
"58 24 a
the adjacent peaks of CI and Na.
(b) Coincidence peaks at high energies from the
much larger photopeaks at lower energies.
(c) Any 57S produced from the 57Cl(n,p)57S
reaction, which'has a peak at 3.1 MeV.
Taking these in the inverse order, there was no
37
possibility of significant interference from S using
252 37
moderated neutrons from Cf. CI has a threshold of
activation of 3.5 MeV and the very low number of neutrons
above this energy that were present after premoderation
37
ensured negligible activation of the CI, even though
1 4-8
the product of atoms.gm .0" , is comparable to Ca.8lC~G
The effect of summing the 1.60 MeV peak of ^®C1 and
the 1.37 MeV peak of ^Na was investigated. Analysis of
a spectrum from a cadaver limb showed that these were the
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only peaks whose summing could produce an error in the
calcium region. Three perspex tubes 20 cm long and
internal diameter 1.2 cm were filled with either NaOH,
CaCl^or H2O. The two tubes containing the NaOH and CaCl^
were irradiated so that the ratio of the activity of the
^Na and ^®C1 was similar to that of the cadaver limb.
The tubes were measured together in the part-body counter
and then separately with the water tube, and the spectra
were measured from 2.9 to 3.1 MeV. No evidence was found
of any significant contribution to the background from
the summing of the two peaks at 2.97 MeV.
The main interference to the calcium counts was from
24
neighbouring peaks, in particular, Na. Now the peaks
of ^Na and ^Ca at high energies were not simple photo-
peaks but both had a lower secondary peak at 0.511 MeV
below the photopeaks (Pig. 4.1). These peaks were due to
the escape from the crystal o£ one of the products of pair
production which occurred at high energies. Close exa¬
mination of the calcium standard spectrum revealed an
extremely small peak at 1.02 MeV below the photopeak due
to the escape of both pair production products. The
presence of this secondary peak meant that it was not
possible simply to integrate over the sodium photopeak
and then calculate the percentage contribution in the
calcium region.
The technique that had been frequently used to
calculate the sodium contribution, particularly in whole
49



















measure the contribution of the two longer lived isotopes.
This technique however was not suitable in partial body
24
sites because of the recirculation of particularly Na
in the soft tissue. It has been shown (Spinks et al
1976a) that the clearance half time for sodium in the hand
can be as short as 26 min, thus any value of the sodium
contribution could be grossly underestimated.
Two methods were used to calculate the calcium con¬
tribution by comparing the complex spectrum with standard
spectra from the separate elements which were irradiated
and counted in the same geometry. Both methods have their
advantages and were used on all patient data to obtain a
direct comparison.
4.2 Simultaneous Equations Method
This method enabled a quick and fairly accurate deter¬
mination to be made of the calcium contribution in the
patient spectrum without the use of a computer. It wasi
38
assumed that the contribution from CI was negligible and
so the following integrations were performed on the complex
spectrum and the two standard spectra. The standard
spectra were obtained by irradiating and counting bone¬
like phantoms in the same geometry as used for the patient
spectrum. The standards were long perspex tubes of










counts in complex spectrum in region 2.94/3.30
" " » " » " 2.60/2.94
11 " calcium standard " " 2.94/3.30
" " " » " " 2.60/2.94
" " sodium standard " " 2.94/3.30
» " " " » " 2.60/2.94
So if x = scaling factor for calcium Std
and y = . 11 sodium
PCa ~ xCCa + ySCa
PNa xCNa + ySNa
Hence the values x and y were easily calculated and
the calcium contribution in the 2.9/3.3 MeV range was
determined. The activity measured in the standard
spectra was such that C^a and S^a were each greater than
4
10 Counts, so statistical errors in the standards were
minimal.
4.3 Spectral Stripping Method
This technique was considerably more complicated than
the previous one in that it required the use of a computer
if it were to be used routinely for large numbers of
patient measurements. It basically involved fitting the
three standard spectra simultaneously using a least
squares technique to the complex spectrum. The following





no. of points in spectrum
counts in ith channel of patient spectrum
counts in ith channel of kth standard spectrum
scaling factor of the kth standard
Wi ; weighting factor of each point
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0=1 i=l i=l (k = 1,2,3)
Expressed in matrix form:
,TS¥S Z = SV/P
Z = (S¥ST)"1SVP
where
z = a 3 x 1 column matrix of unknown scaling factors
s = a 3 x 200 matrix. 200 spectrum points are used
ST = a 200 x 3 transpose matrix of S




a 200 x 1 column matrix of the complex spectrum
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A computer programme was written in Fortran IV to
compute the value of Z^. Initially the programme was
written for a Rad 8 computer with 16X core memory but it
has subsequently been transferred to a Varian V72 machine.
In addition to fitting the three standard spectra to the
complex spectrum, it was possible to correct for any drift
that had occurred in the electronics (Sec-ion 3.2).
The patient spectrum and the sodium and calcium
standard spectra, in the energy range 1.8 MeV to 3.4- MeV,
were stored on paper tape which was fed into the computer.
The calcium and sodium standard (Section 5.5) were measured
each day to check the apparatus and the relevant day's
standards were always fed in with the patient tape. A
•Z Q
single CI standard was stored in the computer and used
for all the calculations.
Once the data had been fed into the computer, the
patient spectrum was smoothed by fitting a polynomial
(Quittner 1972). This method was chosen in preference to
a weighted mean technique because it was less likely to
distort the peaks and valleys of the spectrum. The
F.W.H.M. of the calcium peak was about 16 channels so a
13 point polynomial of the second degree was fitted to the
spectrum (Fig. 4.1(b)).
After smoothing the patient spectrum, the product SW
was computed. The weighting matrix was a combination of
two separate weighting factors so that:
W. = oCi x f(Pi)
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where = for 1 ^i ^89 1.80 MeV to 2,50 MeV
= 3 for 90 <i <139 2.50 MeV to 2.90 MeV
= 5 for 140 <i < 200 2.90 MeV to 3.40 MeV
and f(Pi) =
It was thought necessary to include cC to weight
different portions of the spectra because the main peaks
had progressively larger amounts of interference from
other peaks as the energy decreased. The values of oC.
were determined experimentally from eight repeated
measurements of a cadaver limb. The values of 1, 3, 5
above were found to improve the standard deviation of the
eight measurements from when a value 0(h = 1 for i = 1,
200 was used. As the standard deviation of each indivi¬
dual point in the complex spectrum approximated to
the second comp'onent of the weighting factor was thus
chosen so that the weighting between points was propor¬
tional to their relative errors. The value of f(P^) was
equal to the inverse of the statistical coefficient of




The programme then computed the matrix SWS and
inverted this 3x3 matrix using the Gauss-Jordan
technique. Once the scaling factors had been obtained,


















The standards were then shifted to correct for drift.
This was done iteratively by moving the standards indivi¬
dually, in the order CI, Na then Ca, and recalculating
2
until the minimum % value was obtained. The standards
fitted to a typical patient spectrum is shown in Pigure
4.1(c). A block diagram of the program is shown in Pigure
4.2 and a listing is given in Appendix III.
4.4 Comparison of the Methods of Spectral Analysis
The intrinsic accuracy of the two methods of spectral
analysis was obtained by repeated measurements on a patient
spectrum which was randomly altered within its theoretical
statistical limits. A patient spectrum was chosen at
random and each of the 200 points, P(l), in the region
1.8 MeV to 3.4 MeV was randomly changed in a normal dis¬
tribution with a mean at P(I) and a standard deviation
yp(D.
Now normally distributed random numbers were obtained






z xi- 4i=l d
Y = — ___(!)
12
where x^ were uniformly distributed random numbers
0 < x^ < 1 (Hamming 1962). The value Y was sufficiently
normally distributed with the value K = 12 which simpli¬
fied the equation above:
1=12
Y = 21 xi ~ 6-0 (2)
i=l
Normally distributed random numbers X"*" about a value X
which had a standard deviation S were therefore:
X1 = Y x S + X (3)
The single patient spectrum P(l) was altered using
an array of 200 normally distributed random numbers,
RAND(l), using equation (2). The values of RAND(l) were
obtained using the uniform random number generator which
was available in a PDP 11 computer. The values of
RAND(l) were tested for normality using equation (3) with
values X = 10,000 and S = 100, and a histogram was plotted.
The resultant mean and standard deviation of all the
values was 10,000.63 and 97.81 respectively, 69% of all
the 200 values being within 1 S.D. of the mean, and the
histogram gave every appearance of being a normal distri¬
bution. The patient spectrum was therefore altered and
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became:
For I = 1,200
P(I) = P(I) + RAND(l) x (P(I)P~
The patient spectrum was altered in this way and pro¬
cessed using both the simultaneous equations and matrix
method of spectral analysis. This was repeated 12 times
starting at different places in the array RAND(l), and the













Mean .0059969 4535.7 .0065815 4655.9
S.D. .00030858 96.9 .00039446 109.9
C.V. 5.15$ 2.14$ 5.99$ 2.36$
It can be seen that the matrix method of analysis
gave a lower coefficient of variation for both sodium and
calcium. The 2.6$ higher calcium count and the 9.8$
higher sodium contribution obtained using the simultaneous
equation method was due to the absence in the calculation
38
of the contribution from CI.
An additional error that could be present in the
simultaneous equations method was that of drift in the
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electronics (Section 3.2). The integration of the patient
spectrum was performed between fixed channel intervals on
the M.C.A. so if any drift had occurred in the time be¬
tween the patient measurement and the standard measurements
an error would be introduced. Poor statistics in the un-
smoothed patient spectrum on the multichannel analyser
made it impossible to judge a drift of up to 3 channels
(= 24 KeV) in either direction. The possible error due to
drift is shown in Figure 4.3.
FIGURE 4.3







The matrix stripping technique, with its greater
intrinsic accuracy, and its ability to correct for drift,
appeared to be superior. With a fast paper tape reader,
the data could be fed quickly into the computer and so
analysis took only a matter of minutes for each patient.
However a fairly large computer was required to process
the data in a reasonable time, whereas the simultaneous
equation method could be used with very modest facilities.
In the following chapter, both methods are compared using
a large number of patient results to determine whether





REPRODUCIBILITY AND IRRADIATION PROGRAMME
The two topics of firstly reproducibility, the pre¬
cision of the method, and secondly the irradiation pro¬
gramme, when, and how patients are to be measured, are
discussed together in this chapter because of their inter¬
dependence. It will be seen how initial phantom measure¬
ments of the reproducibility determined the irradiation
programme, and how this in turn led to a much more accurate
estimation of the reproducibility.
5 .1 Cadaver Reproducibility
Using the first irradiation geometry, eight repeated
measurements were performed on a cadaver limb. These
measurements were performed over a period of 24 days so
that sufficient time elapsed between measurements to let
the ^Na decay. The timing was the same for all eight
measurements; 10 min irradiation, 2 min delay and 1000 s
count.
Perspex tubes of Na and Ca were also irradiated to
obtain standard spectra and the calcium counts from the
cadaver limb were calculated using the method of simul¬
taneous equations. The standard deviation of these values
was taken as the reproducibility and was found to be 3.33$
(coefficient of variation) of which 2.23$ was due to
counting statistics.
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Prom the figure for the reproducibility of the method,
it was possible to state the percentage change that could
be measured in a patient over a period of time with anp
degree of significance. The calculation of the "least
significant change",'however, varied considerably from
one centre to another where sequential patient measure¬
ments were being performed. In view of the importance of
this figure for interpreting individual patient results,
this situation gives cause for concern.
The Washington group (Nelp et al. 1972b) stated that
changes of il S.D. were measurable, as did the Aberdeen
group (Catto et al 1973b). Also in clinical studies at
Brookhaven (Cohn et al 1971), changes of greater than
1 S.D. were said to be significant. In Birmingham how¬
ever (Hosking et al 1972a), the reproducibility was
quoted as 1.7$ and the least significant change as 4$
which was 2.35 S.D.
One problem was deciding on the degree of signifi¬
cance when calculating the least significant change from
the reproducibility figure. In the following analysis of
the least significant change, the level of significance
was taken as p<0.05, which was thought to be necessary
for patient studies.
5.2 Lease Significant Change
The standard deviation (reproducibility) of the
cadaver measurements, S, was an estimate based on 8 values}
of the true standard deviation CT . Consider two measure-
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separated by a time interval to be x^ and Xg
The change is significant iff:
X1 ~ x2 x S x ^m-1
>42" x 3.33^ x 2.37
(S1— S2)
Least significant change = 11.1'ojo (p <0.05)
This value was too high for patient studies to be
feasible in the short term. The irradiation time for the
cadaver measurements was 10 min so little would be gained
by increasing the irradiation time; the reduction in the
statistical contribution of the reproducibility would be
minimal compared to the increased dose.
Permission was obtained from the M.R.C. for an annual
dose equivalent to 6 measurements, so a decision had to be
made when these were to be performed to measure a change
over a 6 month period. The least significant change was
calculated in the three following situations.
(i) Six measurements x^...Xg at monthly intervals t^...tg
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b = slope/month =
S.E.(b) =
(xi - x)(ti - t)
(ti - t)2
(T(h -^
Least significant change = -=r x S x t
V70 m_i
= 9.43$ (p < 0.05)
(ii) Three sets of two measurements x-^, x^, x^ at times














Least significant change = 7.89^ (p <0.05)










Least significant change = 6.4-4jo (p <0.05)
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5.3 Irradiation Programme
In the previous section it is seen that two sets of
three irradiations give the lowest value of the least
significant change. In the first sets of patient studies,
changes were expected over a six-month period, so the two
sets of three measurements were adopted as the most sui¬
table irradiation programme.
One additional advantage of repeated sets of three
measurements on patients was that a much more accurate
reproducibility figure could be obtained. By combining
the standard deviations of all the sets of three measure¬
ments, a figure for the reproducibility was achieved which
included patient movement, a factor which was ignored when
phantom or cadaver measurements were performed. In addi¬
tion the final value of S obtained would be based on a
very large number of results so the figure for "t p would
tend to 1.98.
It was also felt that no extra information would be
gained by six separate measurements because changes over
this period were likely to be so small that it would be
impossible to follow the trend of any gain or loss.
3.4 Patient Reproducibility
Using the sets of three measurements from the patients,
reproducibility figures were obtained for both irradiation
geometries using both data processing techniques. Prom
each set of three readings the mean and the standard
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deviation were calculated, the latter "being divided into
two components C.V.g and C.V.^ where:
C.V.g = statistical coefficient of variation
C.V.M = coefficient of variation due to other
variables such as movement etc.
These were calculated from Ca, the mean calcium counts in
the range 2.9/3.3 MeV and G.Vthe total coefficient of
variation.
n v .* = a/ Ga + bgd
s
Ca
g,v,m = v7(c.v.T)2 - (c.v.s)2
It was necessary to separate the two components in this
way because of the large variation in Ca from patient to
patient and hence the large variation in C.V.g. The com¬
ponent C.V.M should be independent of Ca and so was eal-
©
culated separately. All the values from the different
patients were combined to give a C-V.^ for the different
irradiation geometries and processing techniques.
2
A histogram of (C.V.^) , a function of the variance,
of 64 sets of three patient measurements is shown in
Figure 5.1. It is seen that the distribution is exponen¬
tial, as would be expected from a homogenous distribution
of sets of three measurements. If the number of measure¬
ments in each set were to increase, so the histogram would




Histogram of (C.V.j) of 64 sets
of triple patient measurements
(C.V.y)2
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analysis of patient data is shown in Table 5.1. Included
in the table is a figure for the mean total coefficient
of variation (C.Y.and the least significant change
(l.S.C.) based on a calcium count of 2025 and 5501 for
irradiation geometries (A) and (B) respectively. These
values of the calcium counts are the means of all the q
calcium counts for each geometry with the initial sources.
TABLE 5.1
Matrix Method Simultaneous Equations




(A) 2.20 3.14 5.13$ 2.66 3.45 5.63$
(B) 1.93 2.57 4.20$ 2.04 2.65 4.33$
where the number of sets of three measurements that these
results are based on were 75 and 68 for irradiation geo¬
metries (A) and (B) respectively.
The L.S.C. was calculated assuming two sets of three
measurements will be made. It is seen that irradiation
geometry (B) was superior, as was expected, and that the
matrix method of calcium analysis was marginally better
than the simultaneous equations method. The precision
(standard error) of the mean of each set of three measure¬
ments for geometries (A) and (B), using the matrix method,
was 1.81$ and 1.48$ respectively. It was felt that
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p<0.05 was the necessary level to determine significance
in the individual patient and so the relevant value was
used to determine the least significant change.
5.5 Apparatus Stability
The long term stability of the apparatus was demon¬
strated from the calcium standard measurements that were
performed on each day that a patient was measured. Figure
5.2 shows the standard measurements with the water bath
and the new sources over a nine-month period.
The occasional low standard value was due to the end
of one of the source delivery tubes not being pushed fully
into the wax reflector. The frequent changing of the
irradiation apparatus, or the use of the chamber for
experimental purposes, made such occasional mistakes
inevitable.
A more serious problem was discovered in the irra¬
diation apparatus from the standard results (not shown in
Figure 5.2). When the water bath was first used for patient
measurements, it was discovered that, over the first month,
the gradual decrease in counts from the standard was
«•
greater than could be accounted for by the decay of the
252Cf sources. Examination of the apparatus showed that
warm water in the water bath had caused the sides to bulge
slowly, thus gradually increasing the source separation.
The water bath was subsequently strengthened and the
standard values used to correct the patient values.
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Figure 5,2































Details have been given in the preceding chapters
concerning the basic method for clinical neutron activa¬
tion measurements. In this chapter details will be given
of the procedure adopted for patient measurements, both
with respect to activation analysis and to other existing
methods of measuring the calcium status of a patient,
with which comparisons will be made.
6.1 Activation Analysis
The initial contact with a prospective patient was
made by one of the medical staff associated with the
project. The purpose of the particular study was explained
from the medical point of view and once the patient's con¬
sent had been obtained, the physicist explained exactly
the practicalities that were involved for the patient.
Once the patient's consent had been obtained, the only
criterion for his removal from the study was at his own
request.
At the start of the patient's first visit for acti¬
vation analysis he was shown how to sit and position him¬
self in the partial body counters. This was essential to
reduce the delay time between activation and detection.
The height of the chair was adjusted and positioned so
that his forearm was horizontal and his shoulder in line
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with, the arm rest.
The patient was moved into the' irradiation chamber
which was about 25 m distance and positioned in the irra¬
diation apparatus. V/hen irradiation geometry A was used
the patient was positioned with his arm horizontal and
with the hand grip at the centre of his clenched first
(Pig. 6.1a). The separation and the position of the
reflector/premoderator assemblies were checked and the
top wax block placed in position. With irradiation geo¬
metry B the patient was positioned with his arm at an
angle of 45° in the water bath which had previously been
warmed to a comfortable temperature (Pig. 6.1b). The
patient's arm was strapped into place making sure that his
forearm was resting on the arm rest along its entire
length and then the level of the water was adjusted so
that it was level with the overflow.
After warning the patient that the sources were likely
to arrive into position with a loud "blick" and reminding
them not to dawdle between the end of the irradiation and
the start of the counting, the operator withdrew from the
activation chamber and delivered the sources to the irra¬
diation position. Once in position another burst of air
was sent along the delivery tubes to ensure that the
sources were in the correct position at the end of the
tubes. Although this was done on every occasion it was
only very rarely that the sources bounced back off the end
stop when delivered into position the first time. The
patients were irradiated for 10 min before March 1977





dates, a stopv/atch being used for all the timing.
At the end of the irradiation the patient was moved
into position in the part body counter generally with a
delay of 1 min (Pig. 6.2). All the times were recorded
so that the data of the patients whose delays were longer
than 1 min could be corrected. The induced activity was
measured for 1000 s, the timing being done automatically
on the multi-channel analyser, though it was regularly
checked with the stopwatch.
The three repeated measurements were performed at
weekly intervals on the first group of patients studied,
so each visit lasted about half an hour. This, unfor¬
tunately, was not possible with some of the later patient
groups because the patients were unwilling to make repeated
visits to the hospital. Hence the three measurements were
repeated at hourly intervals after which time any activated
calcium had nearly all decayed. The exact time interval
between activations was noted to correct for any residual
24
calcium. The activated Na rose during the three mea¬
surements but in general the gross counts in the ^"Na
region after the third measurement were approximately
twice that after the first.
Before starting the patient trials some measurements
were performed on patients' tibiae. The irradiation
geometry was in principle the same as geometry A and
photographs of irradiation and detection of tibia are
shown in Figure 6.3.
On each day that patient measurements were to be
performed the E.H.T. supplies and the amplifier gain were
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FIGURE6.2
Partialbodycountermeasu ingforearmwi hthc n reshi l .
FIGURE 6,5
calibrated using 2^Na and ®Co first thing in the morning.
The background was then measured with a wax arm phantom
in the counter for 1000 s and stored in the second 512
channels of the analyser. The calcium standard was acti¬
vated at mid-day for 30 min and counted for 1000 s
following a one minute delay, care being taken to position
the standard in the same place each time. Also at mid¬
day the sodium standard was measured, though it was not
irradiated or counted for a specific length of time, but
just long enough so that there were at least 10^" counts
in the region of the calcium photopeak.
6.2 Photon Densitometry
The technique of measuring the mineral density of
bone by photon absorption has been well documented
(Cameron and Sorenson 1967). The apparatus used for
patient measurements was not one of the commercially
available machines but was constructed in the department
O A T
and used a source of 45 mCi of Am instead of the more
125
suitable I for financial reasons.
The measurements were performed on the forearm at a
distance 5 cm from the distal end of the radius. This
was not the most uniform section of the bone but was
likely to contain trabecular bone. The patient's arm
rested in a water bath in such a position that his hand
gripped a rod of perspex with his knuckles resting on the
base of the water bath. The patient's humerus was held
Q
vertical with his elbow resting on the base of the water
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bath. In such a position the radius and ulna were held in
a fixed position and did not overlap. The arm was strapped
firmly in position using velcro straps and the bath was
filled to cover the patient's arm (Pig. 6.4).
The detector was placed about 1 cm above the water
level and the source and detector were scanned manually
across the forearm. Attached to the detector was a 1.2 cm
long and 0.5 cm wide collimator. Experiments scanning
across a straight edge of aluminium gave a figure for the
resolution, from 90$ to 10$ attenuation, of 0.26 cm. The
aluminium was thick enough to give' attenuation similar to
a normal radius, and it was positioned 2 cm above the base
of the bath. The maximum count rate obtained with a
normal level of water was about 10,000 counts.sec"^.
With the patient's arm in position, the source and
detector scanned across the radius in millimetre intervals,
counting for 5 s at each position. At least 20 measure¬
ments were made before reaching the bone to enable the
base line to be determined as accurately as possible, a
O A T
precaution necessary when using Am. Three complete
traverses of the radius were made and all the data were
collected on punch tape to be fed into the computer.
A result is shown in Figure 6.5 which illustrates all
the possible problems involved in obtaining a figure of
the mineral density. The major source of error is the
baseline, as a change of 1$ in the counts in the base¬
line will give an error of 2.0$ in the mineral density.
The precision of the value of the mineral density, based





Scan across the radius illustrating
possible errors
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6. 3 Metacarpal Index
Radiographs can show changes in calcium content and
there are several methods to quantify such changes. Radio¬
graphs of the hand have been particularly useful in the
past to assess calcium changes in patients with renal
osteodystrophy.
The patient's hand was placed as flat as possible on
a low wooden box with the target of the X-ray tube 1.88 m
above. Packets of non-screen film were used with the
settings 75 KV and 250 mAs for 1 s. The film was then
developed using an automatic processor. Ideally indus¬
trial film should be used and the developing done by hand
to obtain the optimum contrast. This was not feasible
and tests showed that the method used produced adequate
radiographs.
Measurements were made using engineering vernier
calipers on the second metacarpal (Pig. 6.6), and the
values d, D and 1 could be measured to 0.01 cm. Many
formulae have been used, combining the three variables
together, to quantify changes in the cortex. It was
decided to use the formula below for comparison with
neutron activation analysis.
2 2
Metacarpal Index = D - d
This was based.on a recent review of quantitative radio-
grammetry of cortical bone (Dequeker 1976), which stated
2 2
that D - d is a slightly better index to use than the
"combined cortical thickness" = D - d.
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All radiographs were taken "by the same radiographer
and all measurements were performed by the same technician
to reduce measurement errors.
FIGURE 6.6






7.1 Preliminary Patient Measurements
Before starting any clinical trials involving large
numbers of patients it was decided to look at individual
patients whose calcium level would be expected to change
by a fairly large amount over a short time period. Appa¬
ratus similar to irradiation geometry A was used with just
a single irradiation on each occasion, rather than■the
triple irradiation adopted for higher precision in the
clinical trials. The purpose was simply to verify that
neutron activation analysis could detect calcium changes
in the patients.
Three patients were measured, two with Paget's
disease of one peripheral bone but with the contralateral
bone normal, and one patient suffering from hyperpara¬
thyroidism. The two patients with Paget's disease were
treated with calcitonin and responded well to treatment.
The third patient responded well to a parathyroidectomy.
Pigure 7.1 shows the calcium level in patient C.R.
during a 12 week treatment. The limb affected by Paget's
disease had much more calcium than the normal tibia and
there was a lass during treatment which is significant
(p<0.05) as would be expected. No change was detected in
the normal limbs. The same result was found in the other














































normal forearm but a possible significant loss in the
diseased bone in response to treatment (p<0.10).
In the patient with hyperparathyroidism (Pig. 7.2b),
calcium in all the bone would be affected so both forearm
and tibia were measured. As expected, calcium in both
regions rose significantly over a period of 5 months post-
operation (p<0.05).
These initial patient studies showed that large cal¬
cium changes could be detected by neutron activation
analysis. The following clinical trials would evaluate
the technique in more extreme situations, i.e. where very
small changes were expected or where the size of change,
if any, was not known. It was for the purpose of these
trials that the techniques described previously in this
thesis were adopted.
7.2 l-oc-Hydrox.ycholecalciferol and the Treatment of
Renal Osteodystrophy
It is well known that patients with renal failure
may develop metabolic bone disease and this has increa¬
singly become a problem with the extended life expectancy
due to the advances in haemodialysis. In many cases the
treatment of this bone disease has become the major
concern in the management of the patient.
The loss of calcium is probably due to the absence of
a vitamin D metabolite, 1,25-dihydroxycholecalciferol
(1,25-DHGC), which is produced in the kidney (Praser and
Kodicek 1970). Before vitamin D acts in the control of
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calcium metabolism it is converted to a functional form
in at least two metabolic steps. The first, 25-hydroxy-
cholecalciferol (25-HCC), is synthesized in the liver from
vitamin D and is the major form of circulating vitamin D.
The second, more polar, metabolite, 1,25-DHCC, is three
times more active and is derived from 25-HCC by hydroxy-
lation in the kidney (Pig. 7.3).
A small number of patients with chronic renal failure
have been given 1,25-DHCC for periods between two and six
months (Henderson et al 1974). Healing of radiological
rickets was observed but the difficulties in producing
1,25-DHCC have limited its value.
An analogue of vitamin D, which may bypass the renal
hydroxylating mechanism, has been synthesized. This ana¬
logue, l-oc_hydroxycholecalciferol (1-oC-HCC), is fortunately
relatively simple to produce (Harrison et al 1974).
Both short and long term studies have been performed
on patients with chronic renal failure using various
dosages of 1-oC-HCC. 10 daily for a few days was found
to increase calcium absorption two to three-fold, raise
the serum calcium and reduce the serum alkaline-phosphatase
(Chalmers et al 1973). 25 p.g daily was shown to decrease
resorption from bone in renal patients and to increase it
in patients with normal renal function (Peacock et al
1974).
Longer term studies were performed using much lower
dosages and the bone calcium was monitored by neutron
activation analysis. Three patients, all on dialysis for
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FIGURE 7.3
Production and Effects of Vitamin D Metabolites
Bone Skin
Increases 7-dehydrocholesterol
Resorption + UV light
-140-
about five years, were followed over 18 months before
treatment with l-oc-HCC began; a further three studies were
made at intervals of one month after the start of therapy.
The dialysate calcium was 1.5 mmol.l and two patients
received 2 ;ug and the other 1 jig 1-oC-HCC daily. Signifi¬
cant increases in calcium were observed (pcO.OOl) in the
hand in all three patients (Catto et al 1974).
A study was also carried out on four patients over a
period of 10 to 12 months. They were given 0.5 to 2 ^g
l-oc-HCC daily with the dialysate calcium 1.6 mmol.l '
(0.8 mE^.l'). Two patients showed significant biochemical,
radiological, histological and total body calcium changes
corresponding to increased calcium uptake in bone. The
other two patients showed no improvement and one of these
showed signs of deterioration (Naik et al 1976).
The patient studies using l-oc-HCC have not suffi¬
ciently evaluated the effect on bone over a long time
period. Catto (1975) only showed an increased over a three
month period in bone and this was in only three patients
without a control group. In the study over a longer time
period however (Naik et al 1976), the results were incon¬
clusive, partly due to the structure of the study.
A study was set up in Edinburgh, in conjunction with
252
the medical renal unit, to use the Cf apparatus to
evaluate l-oc-HCC. Twenty-one patients aged 26 - 58 (mean
41 years) were chosen for the study, being the complete
population of patients on home dialysis never having
received l-oc-HCC. They had been established on haemo-
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dialysis for 2-11 years (mean 4.5 years) and prior to
the study, dialysis in all patients was conducted with a
dialysate calcium concentration of 1.75 mmol.l \
The twenty-one patients were randomly allocated to
one of three groups. Group 1, the control group, continued
treatment with a dialysate calcium concentration of 1.75
mmol.l-"'". Two patients, however, failed to attend leaving
only five patients in this group. Groups 2 and 3 contained
seven patients each in whom the dialysate calcium concen¬
tration was reduced to 1.375 mmol.l~\ In addition, the
patients in group 3 were given 1-oc-HCC in an initial dose
of 2 yUg daily by mouth. No other aspects of treatment
were altered in any group.
Neutron activation analysis measurement of both fore¬
arms was performed at 0, 8 and 16 months from the start of
the study. Densitometry measurements of the non-fistula
arm were performed at the same time but due to an error,
results could only be obtained at 8 and 16 months. Meta¬
carpal indices were determined at 0 and 8 months.
All patients completed the study with the exception
of one patient in group 2 (Mrs.S.D.) whose dialysate cal¬
cium concentration had to be increased after the 8 month
measurement because of excessive calcium loss.
7.3 Results of the Renal Study
The results from the patients are given in Tables
7.1a, b and c, the figures being the percentage change
from time zero. The calcium counts from neutron activation
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TABLE 7.1a
Percentage Change in Neutron Activation Analysis
Measurements of the Non-Pistula Arm







R. C. -3.98 -4.65 -8.63
W.H. -0.22 -5.73 -5.95
I.R. +2.22 +0.77 +2.99
J.R. -5.11 +1.30 -3.81
T.W. -1.42 -4.45 -5.87
2. Low Ca
J.B. CO9CM+ -2.09 +0.39
* S.D. -8.98 +7.32 -1.66
T.D. +1.55 +0.05 +1.60
D.P. +0.28 +0.96 +1.24
W.I. +2.71 +2.97 +5.68
R.M. +11.73 -8.26 + 3.47
M. W. +4.09 -3.25 +0.84
3. Low Ca
and Ioc
G. A. +7.73 -2.82 +4.91
J.S. +14.86 +4.93 +19.79
C.P. +15.68 +1.67 +17.35
W.P. +11.84 -5.87 +5.97
J.M. +4.07 +4.17 +8.24
C.M. +4.99 -3.15 + 1.84
I.M. +5.64 -0.18 +5.46
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TABLE 7.1b
Percentage Change in Neutron Activation Analysis
Measurement of the Fistula Arm





























J.B. +3.59 -0.59 + 3.00
S.L. -5.16 +2.07 -3.09
T.D. +13.42 -11.85 +1.57
D. P. +4.42 -3.67 +0.75
W.I. +3.45 +1.56 + 5.01
R.M. +11.52 -9.49 +2.03
M.W. +7.18 +2.53 +9.71
3. Low Ca
and Ioc
G.A. +8.18 -0.26 +7.92
J.E. +7.84 -1.35 +6.49
C.F. +7.15 +8.90 +16.05
W.F. + 3.19 -3.81 -0.62
J.M. -4.85 -0.62 -5.47
C.M. +1.57 -0.45 + 1.12
I.M. +13.25 -5.65 +7.60
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TABLE 7.1c




Time Period 8 to 16 0 to 8 0 to 8
months months months
1. Controls •
R. C. -14.30 +7.30 -1.40
V/.K. -4.98 +8.72 + 4.20
I.R. +2.41 -3.94 -3.55
J.R -1.63 - -
T.W. +3.93 -10.13 -54.75
2. Low Ga
J.B. -3.58 -14.62 -16.69
* S.D. +1.94 -6.06 +2.19
T.D. -6.52 - -
D.F. -8.91 - -
W.I. +14.43 +12.32 CM.o1
R.M. -2.47 -6.89 + 1.76
M.W. — -6.79 -19.36
. Low Ca
and Ioc
G. A. +5.54 +13.04 -9.54
J.E. COo•o1 -5.95 +5.76
C.F. +4.98 oo•CM1 -7.26
W.F. -6.49 +74.15 -16.31
J.M. +1.49 +81.98 +3.89
C.M. -4.43 +0.63 -6.28
I.M. i o • o -6.35 -2.19
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analysis measurements at time 0 are shown in Figure 7.4.
This illustrates the wide variation in calcium from one
patient to another. This three-fold variation between the
maximum and minimum was due not only to the size and cal¬
cium loss in the patient but also to the design of the
apparatus. The fact that there was an air gap between the
forearm and the reflectors and premoderators, unlike the
water bath apparatus, meant that soft tissue round the
bone affected the total calcium counts. Patients of s^all
stature will in general have correspondingly less soft
tissue which meant less "reflector" around the bone and
hence a lower calcium count.
Also noticeable in Figure 7.4 is a difference between
the arms of each patient. It is not possible to say
whether the tendency to have larger calcium levels in the
right forearm was due to dominance of that arm in eighteen
out of nineteen patients, or the absence of a fistula in
the right arm in sixteen out of nineteen patients.
The changes in calcium in the non-fistula arm over the
initial 0 to 8 month period is shown in Figure 7.5,as
measured by neutron activation analysis. It can be seen
that the calcium levels in patients in group 5, who
received 1-oc-HCC, increased to a much larger extent than
the other two groups. Because of the relatively small
number of patients in each group, non-parametric statis¬
tical methods are most suitable to analyse the data.
Taking the groups in pairs and using the Mann-Whitney
test (Snedecor and Cochran 1967) the significance of the
difference between group 3 and groups 1 and 2 was p<0.01
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Figure7.4























and p<0.03 respectively. The difference between group 1
ana group 2 was however not significant (p>0.10).
These results were in agreement with the biochemical
findings (Vinney et al 1977) where there was a significant
increase in plasma calcium (pcO.Op) only in group 3. The
metacarpal indices showed no significant differences between
the groups although large increases were recorded in two
patients (J.M. and C.M.), both of whom were in group 3.
No significant differences exist between the groups
when the fistula arm is considered (Nig. 7.6). However
the differences between the changes in the two arms is
very interesting. The difference between the changes in
either forearm is shown in Figure 7.7. Using the Wilcoxon
signed rank test on the twelve patients not receiving
1-cc-HCC, the difference between changes in the two arms
was highly significant (p<0.01). The fact that the cimino
fistula used for haemodialysis substantially increased
venous pressure and therefore might be expected to protect
against bone loss, seemed a possible explanation for this
result (MacPherson 1977).
The calcium measurements over the next 8 month period
showed a different pattern from the first 8 month period.
The patient who was removed from the study (Mrs.S.D.) was
also measured at 16 months and the increased dialysate
calcium was found to increase significantly the forearm
calcium level. Figure 7.8 shows the percentage change
measured in the non-fistula arm by activation analysis,
and no significant differences exist between the groups.
The mean calcium change in the group receiving l-oc-HCC is
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Figure 7.5
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only -0.18$ over the second 8 month period compared with
+9.26$ over the first. Comparing the data in Figures 7.8
and 7.5 the response in each group, taking the non-fistula
arm, over the two time periods, is only significantly
different in group 3 (p<0.0l) which was receiving 1-oC-HCC.
Assuming that the non-fistula arm was most represen¬
tative of overall calcium changes in the patient, it was
seen that l-°c_HCC increases the calcium in bone signifi-
r> T
cantly compared to controls. However this increase was'
not continuous in the long term and 1-oC-HCC had no effect
on the patient over a period 8 to 16 months after the
start of treatment.
Changes in the fistula arm (Fig. 7.9) were lower over
the second 8 month period-than over the first (Fig. 7.6),
significantly so in group 2 (p<0.03). The difference
between changes in the fistula arm and the non-fistula arm
were also significant over 8 to 16 months (p<0.05) but in
the opposite direction to the first 8 months (Fig. 7.10).
This result casts doubt on the proposed explanation of the
effect noted over the first 8 month period.
It was not possible to compare patients on different
dialysate calcium levels not receiving 1-oc-HCC, with any
degree of significance. However, inspection of the data
for both arms over the first time period (Figs. 7.5, 7.6),
suggested that reducing the bath calcium increased the
calcium in the bone. As this effect was not present over
the second 8 months (Figs. 7.8 and 7.9) it may have been
due initially to the fact that the dialysate calcium was
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changed rather than the level itself.
The densitometry results showed no change between the
groups from 8 to 16 months. Comparisons will be made
however between the densitometry and activation analysis
results in a later section of this chapter.
7.4 Anticonvulsant Osteomalacia and its Treatment
with Vitamin D
The effect of long term anticonvulsant therapy on the
bone structure of epileptic patients has been investigated
over the last ten years. Hypocalcaemia and radiological
findings of rickets and osteopenia were reported in 15% of
a German paediatric outpatient epileptic population (Kruse
1968). An even higher proportion has been reported; 30fo
for institutionalised children and 25% for adults (Richens
and Rowe 1970). These figures may be high because the
patients were in institutions and Shaefer (1973) concluded
that the proportion of epileptic patients with some form
of bone disease was between 15 to 25"%.
Experiments have been performed using the two most
common anticonvulsant drugs, diphenylhydantoin (phenytoin)
and phenobarbital. Caspary (1972) reported inhibition of
intestinal calcium transportation in rats by phenytoin in
rat duodenum. Work on patients and rats with phenobarbital
led Hahn (1972) to conclude that the resultant osteomalacia
may be the result of an accelerated conversion of vitamin
D and its active metabolite 25-HCC, to polar inactive
metabolites by drug induced liver enzymes.
Studies on 48 combined drug recipients and 38 controls
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showed significant changes (p<O.Ol) in biochemical values;
plasma calcium and 25-HCC decreased while hepatic and bone
alkaline phosphatase both increased (Hahn et al 1975).
Histological studies on 60 patients on phenytoin showed
an increase in the level of demineralized bone, consistent
with the diagnosis of osteomalacia. The vitamin D intake
of the patients varied from 35 to 980 IU daily and the bio-
chemical values agreed with the study mentioned previously
(Melsen and Mosekilde 1976). A diagrammatic represen¬
tation of the effects of anticonvulsant therapy is given
in Figure 7.11.
Having established the effect on calcium metabolism
of long term treatment with anticonvulsant drugs, vitamin
D therapy was investigated. Using densitometry to measure
the bone mineral content (B.M.C.), Christiansen and R^dbro
(1976) investigated the effect of various types of vitamin
D on the bone calcium. In their first study (Christiansen
et al 1973) the effect of vitamin and placebo was com¬
pared. 226 patients on anticonvulsant drugs were randomly
divided into two groups and given either 2,000 IU/day
plus 390 mg Ga/day, or a placebo plus 415 mg Ca/day. This
was continued for 3 months. Ho change in the B.M.C. was
noted in the placebo group but an average increase of 4$
was noted in the group receiving vitamin The respec¬
tive incidence of raised' serum alkaline phosphatase and
hypocalcaemia was 12$ and 43$. The authors also stated
that a correlation was found between the B.M.C. and the
"load" of anticonvulsants, i.e. the dose (r = 0.24) and
the length of treatment (r = 0.26).
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FIGURE 7.11
Effects of Anticonvulsant Therapy
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The action of vitamin and 25-HCC was investigated
in fifty-four patients who had received anticonvulsant
therapy for at least one year (Christiansen et al 1975).
Nine patients were placed in each of the following six
treatment groups: 200, 100, 50 ;ug daily and 40, 20,
10 ;ug 25-HCC daily. This was given over a period of 12
weeks with an additional 500 mg/day calcium by mouth. No
change was noted in the B.M.C. in either group. However
increases were seen in the serum calcium in the 50 ;ug D^
group (p<0.01) and in the 100 ^ug and 40 jxg 25-HCC
groups (p<0.02).
In a review of their work, Christiansen and R/dbro
(1976) concluded that the B.M.C. of epileptics on anti¬
convulsant therapy was about 88°/o of the normal value. The
B.M.C. could be stabilized with 4,000 IU (100 ^gm) I>2 daily
for 4 to 5 months then 1,000 IU daily to maintain this
level.
Conflicting evidence was available from two other
sources. 50,000 IU/day of calciferol without calcium
supplement was given to ten epileptic and ten normal
patients for a six month period (Linde et al 1972). Gamma
ray densitometry of the elbow and foot showed no signifi¬
cant change in the bone density over this period suggesting
that vitamin I>2 did not affect anticonvulsant osteomalacia.
The beneficial effect of vitamin was shown by
Peterson (1976). Thirty-six epileptic patients were studied,
eighteen with and eighteen without clinical symptoms of
drug-induced osteomalacia. Balance studies showed that
975 IU/day of was required to maintain the osteomalacic
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group in positive calcium balance, whereas the control
group required 380 IU/day. This difference was stated to
be significant at p<0.001 suggesting that vitamin was
a possible treatment for anticonvulsant osteomalacia.
To evaluate the effect of D0 and D- on anticonvulsant2 3
osteomalacia the following study was set up. Thirty-four
patients between 21 and 50 years of age and who had been
on anticonvulsant therapy for at least 5 years were ran¬
domly allocated to one of three groups. Group 1, the
control group, were given a placebo, group 2 were given
100 pig (4000 IU)/day of vitamin D2 and group 3 the same
dose of vitamin D^. The vitamin D therapy was continued
for 6 months and measurements were performed before the
start and at the end of the treatment. Neutron activation
analysis ana densitometry measurements were performed on
the non-dominant forearm, three measurements being done
on each of the two occasions. Calcium absorption, using
45
Ca, and related biochemical tests were also performed
and frequency of fits noted.
7.5 Results of Anticonvulsant Osteomalacia Study
The percentage change in the forearm over the six
month period is shown in Table 7.2 for the thirty-two
patients who completed the study. The results from neutron
activation analysis (Rig. 7.12) show no difference between
the three groups. The three groups showed a mean loss of
0.49%, 0.34% and 0.80% for 1 to 3 respectively. There was
no significant difference between the three groups and
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TABLE 7.2











I. B. 3.62 1.90 6.44
Mrs.J.C. 1.04 -5.99 -3.50
M. C. 1.05 -3.95 -7.00
H.G. -5.75 -13.01 18.53
L.H. -2,44 -5.34 -19.61
Mr. C.H. 0.46 -7.35 -2.40
Mrs.C.H. -2.31 -11.64 7.38
E.L. 2.77 -3.52 1.20
I.N. 1.46 3.79 -3.91
S.R. -5.39 2.06 23.75
GROUP 2:D0
T. A. -0.16 -0.52 11.90
Mrs.J.B. -4.16 -12.90 5.77
Mr. J.C. 4.22 -7.35 -13.45
J.P. -0.92 0.92 45.41
A.H. -6.45 -5.42 -3.20
J.L. 0.70 0.29 -14.76
D.M. 1.27' -14.99 10.96
J.P. 4.50 3.87 -21.36
I.S. 3.27 11.23 1.36
c.w. -5.66 -8.94 -3.79
GROUP 3:D^
Mr. J.B. 0.67 0.09 3.32
J.D. -0.54 -0.57 7.34
E.P. 4.27 2.17 44.06
J.H -1.43 -10.11 5.45
G.L. -0.38 3.22 -
Miss M.M. -2.75 -1.53 -7.20
H.M. 0.35 — 21.56
Mrs.M.M. 0.63 1.58 21.76
A. T. -6.01 -12.35 6.39
M.T. -3.53 12.91 16.48
M.W. -1.97 -15.90 12.65
H.S. 1.09 -4.37 -3.80
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a
certainly nothing like the 4i» increase in the group
suggested by Christiansen (1973) even though the doses of
vitamin D were doubled . The change in calcium, whether
positive or negative was independent of the number of
drugs and length of treatment. It was also independent
of the degree of osteomalacia as determined by normalised
neutron activation analysis measurements (see Section 7.8).
The results from the densitometry measurements are
shown in Figure 7.13. It can be seen that there is a mean
loss in each group though this loss was only significant
in the control group (p<0.05). There was no significant
differences between any of the groups themselves.
From blood samples taken at 0 and 6 months the change
in the product of plasma calcium and phosphate should give
an indication of calcium changes. An increase would sug¬
gest a healing of any osteomalacia due to anticonvulsant
therapy. Figure 7.1 If shows the results of these values
for the three groups. An increase was only seen in group
3 which was significantly different from zero (p<0.05).
The difference between the groups is not however signi¬
ficant .
The results from the anticonvulsant osteomalacia study
are somewhat contradictory. Using neutron activation
analysis no change was noted in any of the groups. In the
few patients where significant changes (p<0.05) were noted,
these were not consistent with biochemical changes. Densi¬
tometry results showed a significant decrease in the placebo
group but not any significant difference between the groups.







































































































I>2 group although again no significant changes existed
between the groups.
r\ ?
These results throw grave doubts on the efficacy of
vitamin D treatment for anticonvulsant osteomalacia in the
short term. A lack of any calcium change over 6 months
from the neutron activation measurements would suggest
that the benefits of vitamin D therapy do not justify the
possible hazards to the patient and the extra medical '
supervision required.
7.6 Calcium Loss Associated with Lithium Carbonate
Therapy
Lithium is widely used in the treatment of bipolar
manic-depressive illness and in Edinburgh at present there
are over 500 patients on long term treatment with lithium.
The mode of action of lithium and many of its side effects
have been investigated (Glen 1977) although as yet the
question of calcium loss from patients taking lithium has
not been fully answered.
Studies on rats showed that lithium appears to inter¬
fere with the distribution and handling of magnesium, cal¬
cium, sodium and potassium ions in brain, bone and muscle
tissue (Birch and Jenner 1973). The rats were given lithium
for a period of 28 days (1 mEquiv/Kg body weight/day) and
in the bone tissue the lithium levels increased from 0.16
to approximately 1.00 mEq./Kg, while the calcium fell from
8891.0 to 8535.0 mEq/Kg, a loss of 4.0$. It could be seen
from this that lithium was not simply replacing calcium ions
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in bone on a one to one basis, as the calcium loss was much
greater than the lithium increase. Previously Gotfrebson
and Rafaelson (1970) have shown that lithium-treated rats
secreted significantly more calcium in urine than controls.
Lithium retention in bone has also been confirmed in
man (Birch 1974) though not calcium loss from bone. Chris-
tensson (1976) reported six female patients who had been
on lithium for 2-4 years. All developed hypercalcaemia
after an average of one year without any other manifesta-
tions characteristic of hypercalcaemia such as subperio¬
steal resorption on skeletal X-rays. No evidence of in¬
creased urinary excretion of calcium was found though the
serum calcium was significantly raised, the latter sugges¬
ting a favourable response to lithium (Glen 1977).
A loss of 15°/o of the bone density of patients treated
chronically with lithium was verbally stated (Hullin et al
1977). These data never appeared in print, however, so
doubt must be cast on their validity.
A study was set up in Edinburgh to monitor any calcium
changes in patients about to commence lithium treatment for
the first time. All patients between the ages of 21 and 65
were considered for the trial and were only excluded if they
did not wish to participate or if their symptoms made the
measurements impossible.
Neutron activation measurements of the non-dominant
forearm were made before the start of treatment and after 6
months. The water bath and sets of three measurements were
used on all occasions. Densitometry measurements of the
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same arm were performed every 3 months when possible.
Blood and 24 hour urine samples were also taken for
analysis.
In addition to the information that would be obtained
concerning the effect of lithium, this study produced the
only set of "normal" neutron activation measurements,which
were obtained from the patients before lithium therapy. A
special note was made of any treatment in the past, such
as EOT or imipramine (Faragalla and Black 1970), which
could have affected the "normal" calcium level in the bone.
When structuring the study it was not possible to in¬
clude a control group because of the ethical problems of
either withholding treatment or irradiating normals.
Another problem in the study was the 50$ dropout rate due
to the cessation of lithium treatment or the refusal of the
patient to return for the 6 month measurement.
7.7 Results of the Lithium Study
The results of the eight patients who completed the
study are shown in Table 7.3 and in Figure 7.15. The mean
loss of calcium by N.A.A., 2.47$, was not significant in
the group as a whole though in two patients, M.P. and
M.H., their individual calcium losses were significant.
This net loss of calcium, as measured by neutron acti¬
vation analysis, was the opposite to the findings from
densitometry. It can be seen that the bone mineral density
increased, especially over the initial 3 month period.
This average increase of 5.18$'and 2.38$ during the periods
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0 - 3 m. and 0 - 6 m. respectively, could be due to the
replacement of calcium by other elements, thus increasing











7.8 Absolute Calcium Levels
Although the emphasis of this research was concerned
with sequential calcium measurements, the absolute levels
of calcium in the patient groups are of interest. The
absolute calcium levels in the forearm are proportional
to the calcium counts if some correction is made for the
patient's size. Thus a factor must be found to normalise
the calcium counts and so reduce the variation in calcium
counts between patients which is due purely to size.
Percentage Change in Patients Receiving
Lithium Carbonate Therapy
N.A.A. jo Change Densitometry jo Change
6 m. 0 - 3 m. 0 - 6 m.
3.88 2.65 0.51
-1.90 - -8.32
10.49 p<0.001 5.95 5.82
0.71 7.57 3.12
-2.04 - 6.93
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As stated previously, the initial set of three acti¬
vation measurements on the lithium'patients could he used
as normals. A fairly good correlation (r = 0.84) was
found to exist between the calcium counts corrected by the
standard in fifteen patients and the cube of the patient's
height. This normalisation factor was found to be better
than Ht, Ht/Wt and Ht^/Wt, where Ht and Wt were the
patient's height and weight respectively. Thus all the
initial measurements of patients using the water bath were
normalised by dividing by the height cubed.
In addition to looking at all the lithium and anti¬
convulsant patients, data were available from patients
suffering from thyrotoxicosis. Initial measurements had
been made on ten patients but final measurements on these
patients would not be completed until towards the end of
1978. The results of fifty-six patients expressed as cal-
—1 —
cium counts x std counts x Ht J are shown in Figure
7.16. The values from the patients on anticonvulsant drugs
are in three columns corresponding to the length of treat¬
ment .
The coefficient of variation of the values of patients
in the "normal" group was 12.19$. This shows that a fairly
wide range exists in the normal bone values and thus would
be of little use as a diagnostic procedure.
Bone loss is associated with thyrotoxicosis and from
the normalised data, the mean of the calcium was probably
significantly lower (p<0.10) by 11.9$ than in the normal
group. This suggests that some degree of osteodystrophy




















































registered by subsequent activation measurements.
The data from the anticonvulsant group, however, were
not significantly different from normal. No difference
existed between any of the three different groups in which
the anticonvulsant patients' data were subdivided. This
was unexpected as any degree of osteomalacia should be
expressed as a lowered value of the mean calcium counts.
If no osteomalacia were present in this group of patients,
as the results in Figure 7.16 suggest, it would help to
explain why no change of calcium,with vitamin D therapy,
was measured by neutron activation analysis. Also no
difference was noted between the three groups of anticon¬
vulsant data in Figure 7.16, showing that the "load" of
anticonvulsant drugs had no effect on the absolute calcium
level. The same result was obtained with the densitometry
values, normalised by the width of the radius.
7.9 Comparison of Neutron Activation Analysis
with Other Techniques
It has been shown that a good correlation exists be¬
tween calcium counts, as measured by activation analysis,
and densitometry of the radius (see Section 1.6). The
good correlation was largely due to the fact that both
measurements reflect the size of the patient. In this com¬
parison of different methods it is changes over a time
period that will be dealt with.
The changes between activation analysis and densito¬
metry were correlated for the renal patients, over the 8
to 16 month period, and for the anticonvulsant patients
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(Figures 7.17 and 7.18 respectively). The correlation
coefficients both showed a reasonable correlation,
r = 0.41 (p<0.10) and r = 0.38 (p<0.05). The degree of
correlation was higher than that found by Aloia (1975)
and Cohn (1976) who compared changes in densitometry with
changes in whole body neutron activation analysis.
This level of correlation between the two methods,
measuring changes at the same site, showed that densito¬
metry was not a particularly accurate method for measuring
calcium changes in the bone. In addition there were
several measurements of changes of around 115$ which was
unrealistically large. The range of changes as measured
by densitometry was over twice that measured by activation
analysis, suggesting that the latter was more accurate and
reliable.
No correlation was found with biochemical values in
the anticonvulsant patients. The changes in the Ca x PO^
product, obtained from blood samples and giving an indi¬
cation of the degree of healing of osteomalacia, were
correlated with both activation analysis and densitometry
changes and values of r = -0.11 and r = 0.06 respectively
were obtained. To check that the Ca x P0^_ product was not
simply reflecting the changes in calcium absorption from
the gut due to vitamin D, the changes were correlated with
45
changes in Ga absorption and no correlation was found
(r = 0.07).
As stated earlier, the activation results suggested
not only that vitamin D2 or had no effect, but that
there may have been no osteomalacia present in the first
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Figure 7.17
NAA changes v. Densit. changes
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place. If this were true it may explain why there was no
correlation between the various tests.
In the renal patients no correlation was found, over
the first 8 months, where significant changes occurred,
between activation analysis and metacarpal indices. Using
all the results, correlations of r = 0.16 and r = 0.19
were found in the non-fistula and fistula arm respectively.
When changes of greater than 50$ were omitted, these
correlations became r = -0.06 and r = -0.17.
As significant changes were recorded by activation
analysis this poor correlation would tend to invalidate






CALCIUM MEASUREMENTS OP THE SPINE
While patient measurements were being performed on
peripheral bone, work was in progress to design and build
apparatus that would enable calcium measurements of the
spine to be carried out. Calcium changes in the spine,
particularly the lumbar region, are of great interest
clinically, more so probably, than changes in peripheral
bone. Technical difficulties, however, have dissuaded
many people from attempting direct measurements on the
spine. Instead, much work has been done to register
changes in the spine by indirect methods such as whole
body activation analysis or measurements of trabecular
bone at peripheral sites.
The only direct measurements of the spine by activa¬
tion analysis have been done at Toronto (McNeill et al
1973b) and Birmingham (Al-Hiti et al 1976a,b) and these
have been discussed in Chapter 1. Of these two, only the
method of Al-Hiti measured predominantly the spine, and
the apparatus that was used, a cyclotron, made it an im¬
practical method for most hospitals. Experiments were there¬
fore performed with a view to devising a method for mea¬
suring changes of calcium in the lumbar region of the
252
spine using Cf, with an acceptable dose to the patient
and with a sufficiently high degree of precision. Such a
technique, if it were proved successful, could feasibly be
installed in any hospital.
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8.1 Anatomy of the Spine
The lumbar spine is a region of metabolically active
bone, the spinal cancellous, or trabecular, bone having
approximately four times the turnover rate of dense bone
(Marshall et al 1973). In the lumbar vertebrae approxi¬
mately 15c/° of the bone is trabecular, which is the highest
proportion of any bone in the body. A very high propor¬
tion of this trabecular bone is contained in the bodies
of the vertebrae, the load bearing section, and a symptom
of excessive calcium loss is the appearance of compression
fractures in the body of the vertebrae. Ideally then, any
measurements of calcium changes in the spine should be
designed to measure predominantly the bodies of the verte¬
brae in the spine.
There appears to be some slight disagreement in the
literature concerning the position of the spine below the
skin surface. Al-Hiti (1973a) stated in a graph that the
approximate region of spine extended from 0.5 cm to 6 cm
below the skin surface and quoted non-uniformity of mea¬
surement through the spine accordingly. In a feasibility
study for activation measurements of the spine (Glaros
1975), non-uniformity values were given for the ranges
0-3 cm, 0-5 cm and 0-7 cm.
Both these studies, however, underestimated the depth
of the spine, according to the results of a survey of a
large group of patients (Brinkley and Master 1967). X-ray
films of adult myelograms were measured for 117 males and
80 females, and the distances Dg, skin surface to inter-
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spinous line, and D^, interspinous line to posterior
surface of vertebral body, were noted for all the verte¬
brae. The maximum, minimum and average values for the
lower thoracic and lumbar spine are shown in Table 8.1.
Prom this table it can be seen that the bodies of the
vertebrae are situated at a much greater depth below the
skin surface than was suggested by Al-Hiti or G-laros.
Therefore, in the experiments that were performed with the
252 Gf sources, uniformities of activation and detection
were measured in the range 5 cm to 9 cm.
TABLE 8.1
Depth of Spine below Skin Surface
Ds dB DS + dB
Min Max Mean Min Max Mean Mean
T8 0.4 1.9 1.0 2.9 4.6 3.7 4.7
9 0.4 1.8 0.8 3.1 4.7 3.7 4.5
10 0.3 2.4 0.8 3.0 4.8 3.8 4.6
11 0.3 2.1 0.9 2.9 5.0 4.0 4.9
12 0.3 2.0 0.9 2.6 5.0 4.4 5.3
LI 0.4 2.0 1.0 3.6 5.7 4.7 5.7
2 0.4 1.9 1.1 4.0 6.2 5.0 6.1
3 0.6 2.7 1.3 4.0 6.2 5.2 6.5
4 0.8 3.3 1.7 4.2 5.7 5.2 6.9
5 1.0 3.4 2.0 3.8 5.7 4.7 6.7
Another factor to consider was the distribution of
calcium in the vertebral body. Although calcium changes
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in the bodies of the vertebrae were the main concern, a
proportion of the calcium counts measured would come from
the spinous processes and arches. Counts from these
regions would effectively increase the "background" counts,
as far as vertebral body measurements were concerned, and
reduce the chance of measuring any changes. Care had to
be taken in the design of the method, not just to obtain
49
the maximum number of. Ca counts or to obtain uniformity
of measurement over the whole depth of the spine, but to
reduce the counts from the spinous processes and arches
and to increase the counts and uniformity in the region
5 cm to 9 cm deep.
An indication of the distribution of calcium in a
vertebra is given in Figure 8.1. The histogram was
FIGURE 8.1









obtained by taking four lumbar vertebrae and measuring
their mass distributions, using Archimedes' principle,
assuming that the calcium distribution was similar. The
results showed that approximately 77°/° of the mass of a
vertebra was in the body.
8.2 Detection of Induced Activity in the Spine
Because there are fewer possible variations in detec¬
tion geometry, this was investigated first, so that the
activation geometry could be chosen accordingly. There
were three possible methods of measuring the induced
activity and the sensitivity and uniformity of each of
these were measured using a 20 cm long, 1 cm diameter tube
24
of Na xn a water bath. As a section of the spine was to
be measured, it was felt, that an extended source would be
more suitable than a point source.
Initially measurements were performed using the part
body counters. In the first method a single 15 cm x 10 cm
Nal detector was used without the central shield and posi¬
tioned so that a patient's back could rest against the
detector. The variation in sensitivity is shown in curve
I in Figure 8.2, and the variations in the regions 1 cm to
5 cm and 5 cm to 9 cm were ±30.2$ and ±24.0$ respectively.
The second geometry considered was two 15 cm x 10 cm
detectors used together at an angle of 90° and 100° with
the crystals touching. The variation along the line bi¬
secting the angle between the detectors (curves II, Fig.
8.2) was calculated from measurements of one detector ana
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Figure 8.2
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it was assumed that the skin surface of a patient would
be 8 cm from the point where the detectors touched. The
sensitivity and uniformity, however, were little improve¬
ment on the first method, except over the first few centi¬
metres .
The third and last counting geometry to be examined
used the whole body counter available in the department.
Pour 15 cm x 10 cm detectors could be used, two above and
two .below, with the subject lying on a movable bed. The
position of the detectors was adjusted to bring them as
close as possible to the bed on which the patient would
lie. The separation between the centres of the detectors
was 20 cm in the horizontal direction between each pair
above or below the patient and 41 cm in the vertical
direction between the two pairs either side of the patient.
The variation in sensitivity with depth, using the
whole body counter, is shown in curve III in figure 8.2.
It can be seen that the uniformity is a great improvement
over that for the single detector, due to the bilateral
counting geometry, the variations over the regions 1 cm to
5 cm and 5 cm to 9 cm.being ±11.5$ and ±8.0$ respectively.
Not only was the uniformity good but also the sensitivity,
in the region of the bodies of the vertebrae, was approxi¬
mately equal to that for the single crystal which would
© r
touch the patient's back.
A further advantage of the whole body counter was the
large F.W.H.M. in the direction perpendicular to the plane









Figure8.3 Variationincounti gsensitivity 7cmabovebedofWBC FW.H.M.=43-2cm
4-3.2 cm at a distance 7 cm above the bed, compared with
23 cm at 7 cm from the face of one of the crystals of the
part body counter. This would enable a larger section of
the spine to be activated.
It was felt, also, that it would be easy to position
a patient in a reproducible fashion fairly quickly using
the bed of the whole body counter, and that he would be
less likely to move or fidget if he were supine. For all
these reasons it was decided to use the whole body counter
for the detection of induced activity.
8.3 Activation of the Spine
The problem of choosing the best activation geometry
was much greater than choosing the detection geometry,
because there was a much larger number of variables from
which to choose the optimum combinations. The properties
of the ideal irradiation geometry can be summarised as
follows:
(A) High sensitivity of activation in the region of
the bodies of the vertebrae (5 cm to 9 cm).
(B) Low sensitivity of activation in the region of
the spinous process and arches (0 cm to 5 cm).
(C) Uniformity of activation through the region of
interest (5 cm to 9 cm).
(D) An activation profile along the spine that is
compatible with the detection profile of the
-187-
whole body counter.
(E) Low dose to the skin surface and radio-sensitive
organs, especially the bone marrow.
The properties of the irradiation apparatus depend
on the following variables. More often than not, each
variable will affect more than one particular property of
the irradiation geometry.
(a) Source position.
(b) Thickness and position of premoderator.
(c) Quantity of reflector around the sources.
(a) Presence of a thermal neutron absorber such
as cadmium.
(e) Whether the sources are stationary or moving.
(f) Source strength.
(g) Neutron energy.
An additional complication arises if it were decided
to measure phosphorus as well as calcium. It was considered
when designing the apparatus that the ability to measure
phosphorus was not of prime importance but that it should
be pursued, if possible, on the condition that it did not
interfere with the calcium measurements.
The possibility of theoretically determining the
thermal flux profile, for different values of the variables
above, was investigated. Monte-Carlo techniques would have
to be used (Raeside 1976, Carlson) but the time or facili¬
ties were not available to develop a mathematical model
for the proposed activation apparatus. Other groups have
-188-
used Monte-Carlo techniques for neutrons (Jones and Auxier
1971a, Jones et al 1971, Krishnaswamy 1971a, 1971b,
Nagarajin and Iger 1974) hut the calculations were ex¬
tremely complicated with just simple source/phantom
arrangements. Available Monte-Carlo computer programmes
were investigated (Hannan et al 1973, Frigerio et al 1973)
but they could not have coped with the variations in irra¬
diation geometry that were to.be investigated. An experi¬
mental approach was therefore adopted.
The properties of a whole range of irradiation geo¬
metries were tested using the phantoms shown in Figure 8.4.
The premoderator material, when used, consisted of sheets
of perspex, and the thermal neutron absorber was a sheet
of cadmium 1 mm thick. This thickness of cadmium may have
caused slightly more reduction in sensitivity than was
necessary, as a sheet 0.4 mm thick was used for a similar
purpose in Birmingham (Vartsky and Thomas 1976). The
strength of each source for these experiments was 31 mCi
and both sources were used together, adjacent to one
another.
8.4 Variation of Thermal Neutron Uniformity
with Depth.
The variation in thermal neutron fluence with depth
was the first thing to be investigated in a range of irra¬
diation geometries listed in Table 8.2. Measurements were
made every centimetre using gold foils which were staggered
to avoid excess absorption in the foils nearest the sources.










are shown in Figures 8.5a and 8.5b, the individual data
points, which fit the curves very well, being omitted for
clarity. The results obtained from the curves were the
variation in the region 5 cm to 9 cm, the relative thermal
flux at 7 cm and the approximate position of the peak below
the "skin" surface (Table 8.2).
In all cases where measurements were performed with
and without reflector, the presence of a reflector was
found to decrease the uniformity at depth, to move the
peak thermal flux value nearer the surface and to increase
the flux at 7 cm. When a thickness of premoderator, which
was less than the source to skin distance,was used, the
premoderator was best left against the source to improve
the uniformity at depth and the position of the peak.
This was to be expected because when the premoderating
material was next to the skin its effect as a reflector
was greater than when it was adjacent to the sources. The
amount of premoderator obviously had an effect on the
shape of the curve and, in general, the greater the thick¬
ness of premoderator, the worse the uniformity of thermal
fluence at depth. The presence of the sheet of cadmium
shifted the thermal peak away from the surface but did not
dramatically improve the thermal fluence uniformity at
depth.
From the curves in Figure 8.5 and the results in Table
8.2, it can be seen that geometry 2 gives the best thermal
neutron depth profile. Not only was the uniformity good
in the region 5 cm to 9 cm, but the thermal fluence was
relatively low over other regions of the vertebrae nearer
-191-
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Variation in thermal flux with depth for




Variation in thermal flux with depth for






The neutron and gamma doses were measured in a range
of irradiation geometries using nuclear emulsions supplied
and measured by the National Radiological Protection Board.
In addition to measuring the maximum dose at the skin sur¬
face and at 7.5 cm deep, measurements were made along the
surface of the phantom to obtain the F.W.H.M. of the dose
distribution. The dose distribution was also measured at
7.5 cm below the surface, in the direction parallel to the
spine, using a fission chamber. At this depth the majority
of the dose would come from fast neutrons, so the fission
chamber would give an adequate estimation of the F.W.H.M.
of the dose distribution.
The results of the dose measurements are given in
Table 8.3 which also includes the peak doses that would
be obtained if the two sources were separated by 20 cm.
Such a separation would reduce the peak dose by an amount
which depended on the F.W.H.M. of the dose profile, as is
shown in Figure 8.6. A reduction could also be obtained
if the two sources were placed together and scanned along
a section of the spine. This reduction is also shown in
Figure 8.6.
It can be seen in Table 8.3 that the presence of
reflecting material reduced the skin dose (geometries 2,
15 and 3, 4), which was not expected. This could have






















































































and the fact that the thick shielding wall was about 1 m
or less from the sources, hence reflecting some fast neu¬
trons back to the phantom. The presence of the block of
wax reflector probably eliminated this contribution to the
dose.
FIGURE 8.6
Reduction of Peak Dose Obtained by Separation








8.6 Sensitivity of Calcium Activation
The sensitivity cannot be accurately obtained from
the thermal flux variations with depth (Table 8.2 column
6), because only one dimension was considered whereas the
problem was two dimensional. In addition it must be
remembered that two figures need to be stated for the
AO
spine sensitivity; the total number of Ca counts and
also the approximate number of counts from the bodies of
the vertebrae.
For this reason both the calcium phantom (Pig. 8.4b)
and a cadaver torso were irradiated in different irra¬
diation geometries. The torso was obtained from the
Department of Anatomy and had been stored in formalin. It
was a fairly recent male specimen of late middle age,
height approximately 5 ft 8 in, so any calcium losses due
to osteoporosis etc. while alive, or leaching after death,
would be minimal. The limbs had been severed from the
torso at mid-thigh and at the top of the arms rather than
disarticulated.
The values of the relative and absolute sensitivities
are shown in Table 8.4. Estimations of the absolute cal¬
cium counts from the bodies of the vertebrae were obtained
using the additional information given previously in
Figures 8.1 and 8.2. The irradiation and counting times
for the cadaver torso were 10 min and 1000 s respectively,
o
the latter being performed on the whole body counter. It
can be seen that though geometries 4 and 7 had over twice
as many ^Ca counts as geometry 2, the numbers from the
TABLE8.4
SensitivityofActivationandDetectionf riffere t IrradiationGeometries.
GeometryPre od.S.S,LR flector (cm))
RelativeRelativeS ns tivity thermal fluxatBodyCadaver 7cmPhantom
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No Yes Yes Yes No
0.92 1.00 1.40 2.08 1.71
0.91 1.00 1.40 1.72 1.39
0.49 1.00 1.03
1218 2493 2573
1130 1250 1750 2140 1730
bodies of the vertebrae were not much larger. Thus al¬
though geometry 2 had the lower number of counts, most of
these came from the vertebrae bodies.
8.7 Phantom Reproducibility
As this was by far the most time-consuming of all
measurements, repeated tests were only performed using
geometries 2 and 4, being examples of good and bad depth
uniformity respectively.
(i) Geometry 4; 6 repeated measurements were performed
using the spine body phantom:
Mean = 3314 C.V.T ='2.02#
the number of counts is meaningless; the important
value is C.V. , coefficient of variation due toHI
movement:
°m = 34.43 C-v-m = 1-04^
(ii) Geometry 2; 6 repeated measurements were performed
using the spine body phantom:
Mean = 3439 C.V.T = 1.86#
dm = 25.3 C.V.m = 0.74#
As would be expected, the reproducibility of geometry
2 was superior but not by a great deal.
(iii) Geometry 2; 9 repeated measurements were made
with the cadaver torso:
-2oo-
Mean = 1189.7 CTT = 41.2 C.V.T = 3.5$
Og = 34.5 C.V.g = 2 . 9C/o
= 22-6 C-V-=. = 1-9*
However one of the 9 readings was significantly
different from the rest and it would have been
statistically valid to discard it using Chauvenet's
criterion (Geigy 5th edition) the value being
different from the mean by 5.3a-. If it were discarded
the value for G.V.^ would be reduced to 1.5$.
8.8 Source Strength
The minimum source strength required to obtain ade¬
quate counting statistics over a reasonable time scale
had to be determined. This required the precision of the
measurement of calcium in the bodies of the vertebrae to
be estimated. Now this is not to say that any attempt
49
was made to state the number of Ca counts from the
bodies of the vertebrae, but that the statistical error
of the total counts had to reflect the error in the
49
measured counts from the ^Ca at depth. Such a calculation
of the precision enabled a more realistic determination
of the minimum detectable change of calcium in the spine
and hence the source strength required.
-201-
y Total ^Ca counts + ogd
n v = — —• • ^ • V • q ,Q
4yCa counts from bodies of vertebrae
Assuming C.V.m = 2/ (from cadaver tests)
C.V.T = a/(C.V.S)2 + (C.V.J2
The values used in the calculation of C.V.g are obtained
from Table 8.4 and extrapolations of these figures for
higher source strengths. The results are given in Table
8.5, and graphs of the estimated precision versus dose for
different source strengths and irradiation geometries are
shown in Figure 8.7.
TABLE 8. 5
Estimated Precision of Calcium in the Vertebral
Bodies with Different Source Activities
60 mCi 120 mCi 180 mOi
Geo¬
metry
cT c.v.T c.v.T Ojj c.v.T
4 70.56 5.7/ 122.1 4.9/ 172.8 4.6/
2 42.56 3.8/ 69.35 3.l/o 94.8 2.8/
7 72.26 4.l/o 125.5 3.6/ 177.6 3.4/
Because the precision (C.V.J is expressed as a per¬
centage of the approximate counts in the body of the
vertebra, it will not tend to 2/ at very large activities.
It can be seen that, with 3 times the present activity,
i.e. approximately 180 mCi, a precision of around 3/ could






















































8.9 Optimum Irradiation Geometry
Prom the experiments performed, two irradiation geo¬
metries were considered suitable for spine measurements.
The first, and possibly the best, irradiation geometry
was No.2 where the S.S.D. was 6 cm and no reflector or
premoderator was used. This gave the best uniformity of
activation with depth and the lowest activation of the
252
spinous process and arches of the vertebrae. The Cf
spectrum was not moderated in geometry 2 so it gave the
best chance of detecting phosphorus in the spine. Also,
the lack of reflector and premoderator gave a narrow dose
F.W.H.M. at the skin surface. This meant that, by separa¬
ting or scanning the sources over 20 cm, the peak skin
dose could be reduced to an acceptable level.
Separating the sources by 20 cm changed the F.W.H.M.
of the activation profile along the spine at 7 cm depth.
The value was increased from 20.1 cm to 36 cm, if the
sources were separated, and from 20.1 cm to 25.0 cm, if
the source® scanned 20 cm. This did not unduly affect the
efficiency of detection because the F.W.H.M. of the detec¬
tion profile was 43 cm. Another advantage of viewing a
long section of the spine was that sampling errors from
9
too restricted a field were reduced.
Dose values for spine measurements using two 100 mCi
sources are given in Table 8.6, and the variations in
measurement sensitivity along the spine and with depth are
shown in Figures 8.8 and 8.9.
It must be noted that the effect of either scanning a
-206-
TABLE8.6




















































(a)activationprof lewi hsourc sinfixedp sition.F.W.H.M.=20.lcm (b)„,,scanning20cm.F.Y/.H.M.=25.0cm (c)„„separatedby20cm.F.Y/.H.M.=36.0cm (d)detectionprofilewithh leb dycount r.F.W.H.M.=43.0cm
Figure 8.9
Variation in activation and detection with
















Depth below skin surface
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20 cm region, or separating the sources by 20 cm, was
essentially the same. If the value of 20 cm were to be
increased then scanning would be superior.
The second irradiation geometry which was thought to
be of use for spine measurements used a combination of
reflector, premoderator and Cd sheet (Table 8.6 and Pig.
8.9). The uniformity of activation was not as good as for
the first geometry, but its possible advantage was that
the sensitivity of activation was greater and so may be
of particular use for patients of small stature.
8.10 Design of Patient Irradiation Apparatus
An old dental chair was modified for patient irra¬
diation. The back was removed and replaced by a back rest
in two sections (Pigs. 8.10a,b and 8.11a,b). The lower
section contained a thin perspex window through which the
lumbar spine could be viewed. The complete dental chair
could be tilted back so that the lower back rest was at an
angle of about 30° to the vertical. The upper section of
the back rest could be tilted, pushing the patient's shoul¬
ders forward. This had the effect of eliminating any
lordosis so that the lower thoracic and lumbar section of
the spine touched the perspex window. With the chair
tilted back, the patient's own weight held his back against
the window and prevented any movement.
Attached to the lower back rest were various devices
252
for the Gf sources. The polyethylene source delivery
















Patient in spine irradiation apparatus with




Spine irradiation apparatus from the rear.
The position of the lumbar vertebrae can
be seen against the perspex window.
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to one another, which could be moved up and down inside
two supporting square perspex tubes. The position of the
source delivery tubes could be fixed in the perspex tubes
using a brass screw so that the metal end pieces, where
the sources would be> could be positioned anywhere along
the perspex tubes. The lower ends of these tubes were not
air-tight to ensure adequate air flow for the pneumatic
delivery system. The distance of the perspex tubes con¬
taining the sources away from the lower back rest could be
adjusted in the range 3 cm to 15 cm.
The tubes containing the sources could be moved in
the direction parallel to the spine using the electric
motor at the base and a screwed rod attached to the per¬
spex tubes. This was included in the design of the appa¬
ratus in case it was ever required to irradiate a longer
section of the spine. The region for scanning could be
defined using microswitches, and a tachometer connected to
the motor ensured a constant scanning speed.
The plate at the base of the lower back rest was to
support the wax reflector whenever it was used. A channel
was cut out of the wax reflector so that it fitted round
the rectangular source tube.
The back rests and motor could be folded forward and
the foot support removed to make the chair small enough to
fit into the activation chamber. The chair was mounted on
a plate with wheels for ease of movement in and out of the
activation room. Once in position, jacks in each corner
of the plate could be screwed down to lift the wheels from
the floor and immobilize the chair.
-215-
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The electronics for driving the scanning mechanism
on the chair were obtained from an old Nuclear Enterprises
scanner which was being scrapped. Some modifications and
rewiring were necessary, but eventually a unit was built
which could move the sources back and forth manually or
automatically at any set speed.
8.11 Spine Pilot Study
To evaluate the technique for measuring the spine, a
small pilot study was performed on a group of ten volunteer
252
patients using two 100 mCi Cf sources. Erom this study
a figure for the precision of calcium determination, the
possibility of phosphorus measurement and the most suitable
irradiation programme for patient studies, was determined.
Using the modified dental chair apparatus, a section
of the spine was irradiated for 100s. The sources were
positioned 20 cm apart, the centre of the separation dis¬
tance being in line with the iliac crest. No reflector or
premoderator was used and the centres of the sources were
6 cm from the skin surface. At the end of irradiation,
the patient was measured using the whole body counter with
the crystals as close to the patient as possible. The
delay time varied from just over 1 min to over 3 min, the
most common being 1 min 30 s to 1 min 45 s. The patient
was counted for 3 x 400 s with the iliac crest at the
centre of measurement. The full 1200 s were used to
measure the calcium peak whereas only the first 400 s were
used for phosphorus determination. The procedure was
-216-
repeated three times on all hut one of the patients, who
only had two measurements, there being a gap of at least
one hour between the irradiations. For each patient, the
measurements were all performed on the same day.
The calcium counts were determined using simultaneous
equations, and the phosphorus counts by subtracting the
second set of 400 s counts from the first. The results of
the calcium measurements are shown in Table 8.7a. It can
be seen that for this dose, a calcium count of about 1200
was obtained with a C.Y. due to movement of about 1$.
This gave an overall C.V. of 3.4$. Some of these patients
had Paget's disease so the mean calcium counts may have
been a slight overestimation.
It was found that the method was not suitable for
clinical measurements of phosphorus in the spine. Although
some of the patient spectra had a fairly large phosphorus
peak, five out of the ten had a very small peak
(C.V.g >10$). For further details see Appendix IV.
The apparatus for measuring the spine was developed
mainly to investigate osteoporosis. As this is a disease
in which the calcium loss occurs very slowly, it was
decided to monitor each patient in the proposed study for
about 18 to 20 months. Careful consideration had to be
given to determine the optimum irradiation programme for
the annual dose of 20 rem to the skin and 2.6 rem to the
bone, for which permission was given by the M.R.C. and
the local ethics committee.
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it would be possible, with the stronger sources, simply
to increase the irradiation time to improve the statis¬
tical error and hence reduce the time of each measurement
considerably (Table 8.7b). Prom calculations of the
standard error of percentage change, also in Table 8.7b,
the best irradiation programme was thought to be a single
measurement every four months over a 20 month period. The
patient would then only be required for half an hour for
each activation measurement.
No patient studies have been completed with the spine
apparatus, though several are in progress. In addition to
measuring calcium loss in the lumbar region, to evaluate
different treatment regimes, comparisons are also being
made with changes in forearm both with densitometry and
neutron activation analysis. It is hoped fairly soon to






The design of the apparatus for measurements of the
peripheral bone was found to be successful for the sequen¬
tial clinical studies that were performed on over one
hundred patients. The purpose-built part body counter
reduced the background radiation to levels that were
49
acceptable when measuring ^Oa. During the two and a half
years that they were in regular use they were sufficiently
stable and completely trouble free. In addition the
patients did not complain of discomfort during forearm or
tibia measurements.
The design of the forearm irradiation apparatus was
improved upon after the initial set of measurements on
renal patients although its use was continued for this
group of patients. The use of a water bath, as combined
premoderator and reflector into which the patient's arm
was immersed, had several advantages over the first design.
Firstly, the sensitivity of activation increased for a
given dose. Secondly, the variations in induced activity
due to overlying soft tissue from patient to patient were
eliminated, increasing the possibility of absolute calcium
measurement. Lastly, the precision of the measurement
was improved when the water bath was used.
25 2
It was found that the activity of the original Cf
sources was sufficient for peripheral bone measurements
when hydrogenous reflecting material was used in the irra¬
diation apparatus. This value was much lower than the
minimum activity necessary for patient measurements which
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had been published by Boddy (1974b) and Evans (1976) who
suggested 200 mCi and 500 mCi respectively. A total source
strength of about 50 mCi therefore would be about the
minimum activity required for peripheral calcium measure¬
ments if irradiation and detection apparatus similar to
that described in this thesis were used.
The two methods used to analyse the patient spectra
were compared quantitatively. It was found that the more
complicated spectral stripping method, requiring a com¬
puter with at least 16K core to analyse the matrix algebra,
was better than the simpler simultaneous equations method.
This was so, both when the intrinsic accuracy was compared
using a random variation of a single spectrum, and when
the variation in a large number of sets of patient spectra
were analysed. However the difference between the two
techniques was not great, particularly when the water bath
was used for irradiation. Thus although the matrix com¬
puter technique was superior and should be used where
49
possible, it was not essential for Ca measurements.
The irradiation programme that was adopted for the
clinical studies produced good results but was rather time-
consuming for both the operator and the patient. However
the precision of each set of three measurements was very
good, 1.5$,giving the least significant change that could
be measured between two sets of measurements as 4.2$
(p<0.05). A single measurement with three times the
source strength would give a precision of 2.2$ but as the
error due to movement was 1.9$ an even stronger source
would not approach the precision achieved by the existing
-225-
irradiation programme. The triple irradiations also pro¬
vided a unique opportunity to obtain the precision of the
techniques obtained from the actual measurements of the
patients being studied.
The precision of calcium measurements of the forearm
was better than that achieved by other methods of neutron
activation analysis of peripheral bone. In addition the
dose to the bone was in general less than that given by
other techniques. A single measurement of calcium in the
forearm using the water bath could be achieved with a
precision of 2.51$ and a maximum dose to the bone of 2
rem. Both the groups in Aberdeen and Orsay achieved
poorer levels of precision for higher dose levels (Table
1.2), for their determination of calcium in the hand.
Catto (1973a) stated a precision of 5$ for a dose of 15
rem (Bttinger 1975) using an Am-Be source. Maziere (1976)
achieved a precision of 3$ for a dose of 8 rem using a
252
combination of Gf and Pu-Be. These dose levels were
due mainly to the higher mean energy of the neutron
spectra. The poorer levels of precision would probably
be due to the inherent difficulties of measuring such a
mobile organ as the hand. The group in Lyons(Guey et al
pep
1976), the only other group to be using solely Cf, gave
a dose of 2 rem to the hand and obtained a similar number
of calcium counts as were obtained by our forearm measure¬
ments. However, no figures for the precision of the
method have been stated.
Comparison of the various techniques used for calcium
-224-
G
measurements of peripheral "bone showed that the forearm
was a better site for activation analysis than the hand,
as far as the precision of measurement is concerned. It
252
can also be seen that Cf, with its relatively low mean
neutron energy, was the ideal neutron source for the study
of calcium in peripheral bones because of the lower dose
given to the patient.
Although the characteristics of the apparatus for
forearm measurements were very good and it was success¬
fully used on a large number of patients, there are a
number of ways in which it could be improved. The irra¬
diation apparatus could be constructed in one section with
the wax reflectors rigidly attached to the water bath. The
perspex delivery tubes could.enter the reflectors verti¬
cally, which would ensure that the sources would always be
positioned at the ends of the delivery tubes. This would
also enable the apparatus to be positioned adjacent to one
wall and so be used with the spine apparatus in position.
In addition to peripheral sites, part body measure¬
ments of the spine were investigated. Extensive experi¬
ments showed that an adequate uniformity of measurement
through the bodies of the lumbar vertebrae could be
252
achieved using unilateral irradiation with Cf and bi¬
lateral detection. Apparatus was constructed to irradiate
252
patients using a modified dental chair with two Cf
sources either separated by 20 cm, or scanning a length
of the spine. The tilting mechanism of the chair was used
so that the weight of the patient held his back firmly and
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comfortably in position; this apparatus was tested on a
group of ten patients and it was found that calcium, but
not phosphorus, could be satisfactorily measured.
The precision value of 2.4/6 for a skin dose of 6.6
rem and a bone dose of 0.7 rem compared very well with
/
the two other published methods of spine calcium measure¬
ment; Al-Hiti (1976a) achieved a precision of 3$ for a
dose of 3 rem, whilst McNeill (1973b) obtained a figure
of 6.4/6 for a dose of 0.4 rem. The latter technique,
however, measured a large region 60 cm x 30 cm which in¬
cluded the pelvis and part of the ribs and sternum as well
49
as the lower spine. A similar number of Ca counts were
25 2.
obtained from the Cf method and the cyclotron method
(Al-Hiti et al 1976b), but although the cyclotron had a
higher energy, the precision was worse because the patient
sat upright for both activation and detection, a single
crystal being used for the latter. The technique of
McNeill (1973b) had a large figure for the reproducibility,
probably due to the 30$ less ^Ca counts obtained and to
the fact that a large, fixed length of the trunk was
measured.
252
The characteristics of the Cf method of lumbar
spine measurement showed that bilateral detection and
careful design of the irradiation apparatus could, to a
large degree, compensate for the relatively low energy of
252
neutrons from Cf. A total source activity of 200 mCi
was concluded to be sufficient for a 3 to 4 year clinical
study of changes in the lumbar spine.
-226-
In addition to evaluating the technique of neutron
activation analysis, the patient studies were designed
to try and solve some important clinical problems. The
following conclusions that are mentioned, illustrate the
use of neutron activation analysis of the forearm as a
research tool.
The vitamin D analogue, 1-cc-hydroxycholecalcif erol,
was shown to increase significantly the bone calcium in
patients undergoing haemodialysis. Such an increase was
also found by Catto (1975), although he only performed
measurements for 5 months on a smaller number of patients.
This increase however, was found to stop after 8 months,
and the net change over the next 8 months was approximately
zero. Thus, 1-oC-hydroxycholecalciferol is a suitable
method of stabilising the bone calcium levels, although
further studies may be necessary to determine whether the
calcium level remains constant.
In a large group 6f patients on anticonvulsant therapy,
no increase in calcium,denoting an improvement in their
possible osteomalaciajwas noted during treatment with
either vitamin Dg or D^. This was contrary to the findings
of Christiansen (1975) who used densitometrie measurements
of the forearm. In addition, absolute measurements of
forearm showed that no calcium deficiency was present in
the group as a whole, before vitamin D treatment was started,
compared with normal controls. As our biochemical findings
were in agreement with other workers, it would seem that
there is evidence to suggest that anticonvulsant ostech-
malacia does not exist as such, but that the anticonvulsant
-227-
drugs may affect the biochemical parameters used to deter¬
mine osteomalacia.
The results from the study on bipolar manic-depressive
patients on lithium carbonate therapy suggested that there
may be a calcium loss associated with this treatment. This
study is a case where densitometry measurements would be
expected to be different from neutron activation analysis.
It was suspected that calcium may be lost, but it was known
that the concentration of other elements increased; the
latter was found to be so from densitometry measurements.
The small number of patients make definite conclusions
impossible.
The possibility of absolute calcium measurement was
briefly investigated. Normalising the calcium counts,
252
corrected for the Cf activity, with the cube of the
patient's height gave a variation of 12.1$ (C.Y.) for
normal patients. This suggested that the normal range was
too wide for use as a diagnostic tool for the individual
patient, but that comparisons between groups would be
possible. A significantly lower calcium level was measured
in a group of patients with thyrotoxicosis, as would be
© r
expected, but not in the anticonvulvant group.
Neutron activation analysis was compared with other
methods of monitoring bone mineral changes. Comparisons
with densitometry of the forearm showed a reasonable
correlation between changes measured by the two methods,
r = 0.41 and r = 0.38, for the renal and epileptic groups.
This was the first time that direct comparisons of the two
-228—
methods had been made at the same site and the figures
were much better than the correlations between changes in
forearm densitometry and whole body calcium of r = 0.17
and r = 0.25 found by Aloia (1975) and Cohn (1976)
respectively. Such a comparison of the two techniques at
the same peripheral site was valuable in ascertaining
their relative merits. The degree of correlation however,
was such that no definitive conclusion could be drawn.
The level of correlation was neither high enough to say
that the easier densitometric method is more suitable nor
low enough to invalidate densitometry as a method for
detecting calcium changes. Comparison of changes in meta¬
carpal indices and neutron activation analysis showed no
correlation between the two methods.
In conclusion, the value of part body neutron acti-
252
vation analysis by Cf lies not in its use as a diagnostic
tool, but as a research tool for specific clinical investi¬








Ionization chambers give a measurement of the total
neutron and gamma dose:
Pq = _ii_ x D(t)
WKS
This equation comes from the Bragg-Gray relation where:
P = factor to correct for lack of saturation.
q = charge collected for tissue dose D(t).
t refers to tissue.
M = mass of gas in chamber.
W = energy per ion pair in the gas.
K = ratio of the kerma in tissue to the kerma
in the material of the chamber.
S = ratio of stopping powers of the wall to the
gas for secondary particles generated within
the walls of the chamber.
fin
Now if Co is used as a calibration source then M can be
eliminated:
M ^c ^c Wc ^c ^c-
sjt)
60
where c refers to Co
©
Now also D(t) = D^(t) + Dn(t)
and q = q^ + Gn
-231-
F W K S / \
End) = -n n n an (q - q^)
M
D (t) = -5- — — — — Dc(t) £n ill1 £>^(t)
% Fc Wc Sc Kc " ^ ¥V Ky Wy
(N.P.L. 1974)
In this instance it is adequate to write this as:
Dn(t) = q ZB S Dc(t) _ ( } , }
Fc Wc Sc Kc qc D^(t) (1)
Now |• ^6 = 1.014 ll1° for the cylindrical■^c 1.022 chamber.
•^n
_ 1.016 _ 1.01 tlfo for parallel plate
Fc 1.006 chamber.
ElL = 1.067 i3/°
wc
^n + .
— = 0.988 llfo
Es. = 4.430 ±1 io for cylindrical chamber (over
qc 2 years)
— = 5.986 tlfo for parallel plate chamber
qc (over 3 years)
Kc = 0.995
(Lawson and Porter 1975)
The value q is measured experimentally leaving only
the value Kn tt> be determined from the equation:
-232-
—
= XN(E) dE Ktissue (E) ... (2)
n XN(S) dE Kchamber (E)
The material of the chambers was 10.2$ hydrogen and
89.8$ carbon so the ratio K^i03118/^0^13-111^3^ couid be cal¬
culated for any energy using the data of Bach and Caswell
(1968). This was done at three different energies in the
spectrum:
At 2 MeV Kn = 0.9409
At 0.38 MeV Kn = 0.9770 (This is approximately
the mean energy of
the spectrum)
At 0.5 KeV Kn = 1.0005
Now there was little variation over the spectrum so a
value Kn = 0.977 13.5$ was chosen.
The error in the value of q was 1.04$ from repeated




Measurement of Thyroidal Iodine
Iodine can be measured by in-vivo activation analysis
using the reaction (n,^ ) ^8I. The induced isotope
1 pQ
I decays with a half life of 25 min, and an energy
450 KeV. This low energy presents the main problem in the
measurement of the iodine content of the thyroid because
the background introduces a large error.
252
A total Gf source strength of 45 mCi was used in
the irradiation geometry shown in Pigure Al. This had
been found to be the optimum irradiation geometry for
absolute iodine determination (Boddy et al 1974). The
induced activity was measured using the part body counters
with the thyroid collimators and a shadow shield behind
the neckphantom (Pig. Al). Measurements were performed
with two vials in the position of the lobes of the thyroid
containing a combined total of 56 mg iodine. Dose measure¬
ments were performed using ionisation chambers and a
geiger counter.
A 20 min irradiation, 100 s delay and 1000 s count
produced the results below:-
Detected Counts: 410 KeV-510 KeV
Background 5613
Background with Phantom 5832
Background plus Irradiated 9479
Phantom
Net Iodine Counts 3647
-234-
Dose:
Skin Surface 8.3 rem
Thyroid 6.5 rem
Now the typical quantity of iodine in thyroid gland
is 10 mg although if clinical studies were to be performed
the quantity of iodine could be around 5 mg. The error,
purely due to counting statistics, for a thyroid con¬
taining 10 mg I and 5 mg I would be 16.7% and 33.0%
respectively. An increase in the irradiation time would
increase the dose disproportionately to the increase in
iodine activation due to the irradiation time being al¬
ready similar to the half life of the induced iodine.
252























































































Ct MANATX 22407/77 M MATRIX STRIPPING
PROGRAM MAMATX
C SPECTRUM STRIPPING PROGRAM
C PATIENT SPECTRUM IS SMOOTHED AMD A MATRIX
C TECHNIQUE IS USED TO SIMULTANEOUSLY FIT
C THREE STANDARD SPECTRA TO THE WEIGHTED
C PATIENT SPECTRUM USING A LEAST SQUARES METHOD.
C













COMMON/ARRAYS/U ( 200 ) , X(3) ,YC200) ,ZC200) , A (3. 200)
C COMMON/GRAF1/ITV(4096),XLOU,YLOU,XSCL,YSCL,X0,Y0,IDEV,FX,FY
COMMON/DATUM/CHI











MM ( I ) = 0
DO 290 J-1,3
ALJAT ( I , J ) =0 .
290 CONTINUE
DO 300 K = 1 ,200
A C T , K ) = 0 .




Z C I ) <■ 0 .
Y ( I ) = 0 .






100 FORMATC' SPECTRAL STRIPPING')
URITE(1,108)
108 FORMAT! ' CALCIUM 360/406 ')















72 C NOU DEAL UITH EACH Y VECTOR
73 c
74 10 READ(3,89) PAT
75 89 FORMAT(20A4)
76 URI TEC 9,38)PAT
77 88 FORMAT!'0 ' ,20A4)
78 READ(3,101)Y
79 DO 50 1-1,200
SO 50 IF<Y(I) .GE.900O00. ) Y ( I ) = 0 .
81 0












90 c GENERATE A.U
91 c
92 14 DO 3 1=1,3
93 DO 3 J-1,200
9 4 3 AU(I,J)=A(I,J)XU(J)
95 c
96 c GENERATE A,U.A(TRANSPOSE)
97 c
98 DO S 1=1,3
99 DO S J-1,3
100 A U A T ( I , J) - 0 ,
101 DO 6 K-1,200







109 IF CD.NE.0 . )G0 TO 11
110 URITEC1,105)
11 1 105 FORMAT( ' SINGULAR MATRIX !')
112 NCALC=NCALC+1
113 GO TO 10
114 c
115 c MULTIPLY (AUAT)XX-l BY A.U AMD
116 c TO GIVE X
117 c
118 11 DO 7 1=1,3
119 DO 7 J = 1 ,200
120 AWATAIJ ( I , J ) = 0 .
121 DO 3 K =1,3
122 AUATAUCI,J)-AUAT AU(I,J)+AUAT(I,K)XAU(K ,
123 8 CONTINUE
184 7 CONTINUE
125 DO 9 1=1,3
126 X ( I ) = O .




131 102 FORMATC' RESULTS OF DATA NO',12)
132 URITEC1,103)X
133 103 F0RMAT( ' X VECTOR :',3E20.6)
134 IFCVV.EG.1.) GO TO 104
135 URITEC9,102)NCALC
133 URITEC9, 103 ) X
137 109 FORMAT(' CHI-SQUARED '.E13.S)
138 104 CONTINUE .
139 c
140 c SHIFT STANDARDS
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A1 C
4 2 IFCVV.EQ.2.) GO TO 15
43 C BY HAND
4 4 C CALL MASH IF(VV)
45 C OR AUTOMATICALLY
46 CALL MASHRL(VV)
47 NCAl.C-NCALC-1
48 GO TO 14
49 15 CONTINUE
50 C
51 C DISPLAY COMPLEX-STANDARDSSH C
53 C CALL MAOUT
54 C
55 V = 1 .
56 V = 2 .
57 C IJRITEC 1 , 106) Y
58 106 F0RMAT(6(2X,F8.4))
59 C
GO C CALC. CHI-SQUARED
61 C
62 CALL MACHI2
63 LIRITEC9, 109) CHI






78 112 FORMAT(' ANOTHER SPECTRUM?')71 READ(1,113) NAME
72 113 FORMAT(Al)













































































C# MAPOLY 22/07477 M POLYNOMIAL SMOOTHING
SUBROUTINE MAPOLY












IF(NO.EQ.15) GO TO 60
IF(NO.EQ.13) GO TO 50
IF(NO.EQ.11) GO TO 40














K 3 - 4 4






















K 6 - -13
K7--7S
KM-1105
100 DO 110 1=8,193 .
IA-K7TIYCI-7)+K6*IY(I~6)+K5XIY(1-5)
IB=K4*IY(I-4)+K3XIY(I-3)+K2*IY(1-2)
IC = K1XIY (I-1)+K0XIY(I)+Kl*IY(1+1)
ID=K2XIY( I+2)+K3XIY( I+3)+K4XTY( 1 + 4)
I E = l<5X IY ( I +5 ) + K6XIY ( I+6)+K7XIY( 1+7)




Y C I ) = IJ ( I)
120 CONTINUE
DO 140 1-1,200





1 OS MAUFIT 22407/77 M WEIGHTING FACTORS, STANDARDS AND PATIENT
£ suP.ivoLIT:NE MAWEIT
3 C-QMHON/ARRAYS/U C 200 ),X(3),V( 2O0 ) , Z C 200 ) , A C 3 , 200 )
4 C
5 C OVERALL WEIGHTING FACTOR
6 C
\> C MR I TEC i , 100)
8 10O F GEMAT( ' WEIGHTING CODE >1' '1,2' 'i/Y,3' 'SQRT(Y) WEIGHT' ' ' )
9 C RE'- D (1,110) N
10 110 FORMAT(II)
11C
1R N = 3
13 C
14 DO 1 1=1,200
15 IF C YC I ) . l.E . O . ) Y ( I) =0 .
IS IF(N-2)10,20,30
17 10 W CI ) = 1 .
IS GO TO 1
IS 20 CONTINUE
20 IF(YCI).NE.0.) GO TO 25
21 Y ( I ) = 1 .
2,-J 25 W ( I ) = 5 . 4 ( Y ( I ) )
23 GO TO 1
24 30 IJ( I )-SQRTCYC I ) )
25 1 CONTINUE
20 C
27 C INDIVIDUAL WEIGHTING FOR EACH PEAK
c.'E C
22 C URITECl,120)
3C 120 FORMAT(' CL'NA'CA RATIO'')
31' C READ ( 1 , 130 ) K , L , M
32 130 FORMAT(312)
33 C




03 DO 40 1=1,89
39 40 (JC I ) = U( I )*FLOAT(K)
40 DO 50 1=90,139
4 1 50 W(I)-UK I)*FLOAT(L)





1 OS l-UMV SS/07/7? M MATRIX INVERSION
P. SUBROUTINE IIINV ( A , N , D , L , M >
2 DIMENSION A(i),L(N),r1(h)
-i C
S C GAUSS-JORDAN METHOD OF" MATRIX
G C INVERSION. DETERMINANT IS
V C RETURNED IN ARGUMENT D AND
80 IE D IS ZERO ON EXIT IT INDICATES
9 0 THAT A UAS SINGULAR,
10 0




15 DO SO K = 1 , N
16 NK-NK+N
1 7 L C K ) = K
13 M(K)=K
19 KK=NK+K
20 EIGA = A CKKI
21 DO 20 J = K , N
22 IZ = NTC J-1 I
23 DO 20 1«K,N
24 IJ=IZ+I
25 10 IFCABSCBIGAI-ABSCAC IJ)I)15,20,20
26 15 BIG A = A CIJ )
£7 L ( K ) ■- I
28 M C K ) = J
29 20 CONTINUE
SO C





36 DO 30 1=1,N
3? KI'KHN
38 FIOLD = - A CKI )
39 J I =KI-K+ J
4 0 A C KI)= A C JI I
41 30 A C J I) = HOLD
4 2 C




47 38 JP = NY(1-1)
48 DO 40 J = 1,N
49 JK-NK+J
50 JI=JP+J




55 C DIV COL BY -PIVOT CVAL OF PIVOT
56 C IS IN BIGA
57 C
58 45 IFCBIGAI48,46,48
59 46 D = 0.
60 RETURN
61 48 DO 55 1 = 1,N
62 IFCI-K)50,55, 50




67 C REDUCE MATRIX
68 C
69 DO 65 1=1,N
70 IK-NK+I
71 HOLD = A CIK)
72 IJ'I-N





77 62 KJ = IJ-I-i-K
78 AC I J)-HOLDXACKJJ+ACIJ)
79 65 CONTINUE
AO C
81 C DIV ROU BV PIVOT
82 C
83 KJ = K-N










94 C REPLACE PIVOT BV RECIPROCAL
95 C
96 ACKK) = 1 ,/BIGA
97 80 CONTINUE
98 C
99 C FINAL ROU AND COL INTERCHANGE
100 C
101 K = N
102 100 K =(K-1 )





108 DO 110 J = 1 , N
109 JK-JQ+J
110 HOLD = A C JK)
3. 1 1 J I"JR4J
112 ACJK)=-ACJI)
113 1 10 A C JI)-HOLD
114 120 J = M ( K )
1 IS IFCJ-K)100,100,125
118 125 KI■K-N
117 DO 130 I » 1 , N
118 KI = KI + N
119 HOLD-A C KI)
120 JI-KI-K+J
121 ' A C KI ) = - A C JI )
122 130 AC JI )-HOLD























































IF < VV.EQ.2. ) GO TO 260































110 FORMAT C' STDS CORRECTED ')










G C SHIFT STD TO RIGHT
7 C •












1 cs NSIIIFL 22/07/77 M INCREMENT LEFT TO CORRECT FOR DRIFT
E SUDROUTINE MSHIFLCJJ)
3 COMNON/ARRAYS/UC200) , X ( 3 ) ,Y(200) ,Z(200) ,A(3,200)
4 COMMON/DATUM/CHI
5 C
G C SHIFT STD TO LEFT
7 DO 10 I=1,199
8 J = JJ




13 110 FORMAT(' LEFT '
14 RETURN
15 END
1 Ct MACHI2 22/07/77 M CHI-SQUARED CALCULATION
2 SUBROUTINE MACHI2
3 CO MM ON/ARRAYS/IJ ( 200 ) , X ( 3 ) , Y ( 200 ) , Z ( 200 ) , A ( 3 , 200 )
4 COMMON/DATUM/CHI
5 C
G C CALCULATE CHI-SQUARED
7 C
8 DO 11 J-1,200
9 2 ( J ) - 0 .
10 Z(J)=Y(J )
11 11 CONTINUE
12 DO 12 1*1,3
13 DO 12 J"1,200
1-1 Z(J)=Z(J)-(X(I)XA(I,J))
IS 12 CONTINUE
lc C HI= 0 .
17 DO 13 1=20,190
IS C=0,












Measurement of Phosphorus in the Spine
Phosphorus is measured by detecting the induced
OO yr
Aluminium which is produced via an n, $ reaction which
has a threshold at 2.3 MeV. Calculations were made of the
pep
neutron spectrum (Section 2.6) of Cf at different depths
of premoderation and the following results obtained:
Thickness of $ of neutrons at




3 19 . 5$
5 12$.
7 6.7$
Out of the 10 patients measured, a reasonably large
phosphorus peak was seen in 5 cases. These five patients
were either of small stature with little overlying soft
tissue or they had an artificial hip. This suggests that
the peak was due to the activation of phosphorus in the
spinous processes at a depth where there would be suffi¬
cient neutrons with energy >2.3 MeV. Alternatively, it
could be due in part to a contribution from the reaction
27 OR
Al(n,X) A1 from aluminium in the artificial joint.
Thus phosphorus measurements at a depth of 5 cm - 9 cm,
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